Regioselective synthesis and MS/MS study of alkyl (guanin-9-yl) acetates. Synthesis of of peptide nucleic acid oligomers by HASH(0x7fe96cad6010)
9. Appendices 
I. 
\ 
53 
Fmoc/Acyl protecting groups in the synthesis of polyamide 
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The chemical synthesis of polyamide (peptide) nucleic acid (PNA) monomers 22-25 has been accomplished 
using Fmoc [A-(2-aminoethyl)glycine backbone], anisoyl (adenine), 4-tert-butylbenzoyl (cytosine) and isobutyryl/ 
diphenylcarbamoyl (guanine) protecting-group combinations, thus allowing oligomer synthesis on both peptide 
and oligonucleotide synthesizers. An alternative method for the preparation of (A6-anisoyladenin-9-yl)acetic acid 7 is 
described using partial hydrolysis of a dianisoylated derivative. Different methods were studied for guanine alkylation 
including (a) Mitsunobu reaction; (b) low-temperature, sodium hydride- and (c) A,A-diisopropylethylamine-
mediated alkylation reactions to give preferentially ^-subst i tuted derivatives. Empirical rules are proposed for 
differentiating A®/W'-substituted guanines based on their 13C NMR chemical-shift differences. 
Introduction 
Polyamide (or as originally referred: peptide) nucleic acids 
(PNA) are one of the most powerful analogues of oligo-
nucleotides in terms of chemical and enzymic stability, 
double- and triple-helix formation, with potential applications 
in antisense diagnosis and therapeutics.1,2 In these compounds 
the entire sugar-phosphate backbone is replaced with an N-(2-
aminoethyl)glycine moiety and the nucleobases are attached 
through an A-acetyl linkage. 
The chemical synthesis of PNA mostly relies on the assembly 
of the protected N-(2-aminoethy 1)glycine backbone and pro-
tected nucleobase-substituted acetic acid structural units fol-
lowed by standard oligomerization protocols.3,4 The pioneering 
efforts of a Danish group resulted in the application of Boc 
(backbone) and Z (cytosine, adenine) or O-benzyl (guanine) 
protection.5,6 Later the Uhlmann group used a monomethoxy-
trityl (MMTr)/acyl (anisoyl, 4-tert-butylbenzoyl, isobutyryl/ 
acetyl) strategy.7,8 All these methods require the use of (strong) 
acidic conditions (e.g., TFA, HF) in the oligomer construction 
and final cleavage from the support. The need for milder 
methods led to the employment of the Fmoc group for back-
bone protection and Z 9 or M MTr groups10 for the nucleobases. 
The Fmoc group is a convenient alternative to acid-sensitive 
backbone-protecting groups (Boc, MMTr) and allows easy 
monitoring of the coupling process.11 The combination Fmoc/ 
acyl should also be feasible since the former group can be 
cleaved without affecting the more stable base-protecting acyl 
groups.12-14 Herein we report on our results concerning the use 
of Fmoc (backbone)/acyl (4-rerr-butylbenzoyl for cytosine; 
anisoyl for adenine; isobutyryl/A,A-diphenylcarbamoyl for 
guanine) protecting groups in the synthesis of PNA monomers. 
The prior protecting-group combinations (with the exception 
of Fmoc/MMTr) were used either for peptide or oligonucleo-
tide synthesis protocols. With biologically important PNA-
DNA and PNA-peptide conjugates in mind our approach 
offers a substantial advantage over the existing ones since both 
oligomerization methodologies are possible with the same 
monomers. Beside this, use of the frequently applied urethane 
protecting groups (eg., Z) for nucleobases is not practical as 
in our experience the yields are often very low. This paper 
complements and details our preliminary account.15 
Results and discussion 
The choice of nucleobase-protecting groups was motivated by 
different considerations since uniform protection, though 
attractive, is not possible. Thymine does not require protection 
and our synthesis of the thymine monomer, starting from 
acid 1, was based on the procedure of Thomson et al.9 The 
anisoylated cytosine derivative 2 was alkylated to give acid 3 
(Scheme 1) but the solubilities of these substances were so low 
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Scheme 1 Reagents and conditions-, a, (1) BrCH 2COOMe, K2COj, 
D M F ; (2) NaOH, then HC1; b, AnCl, py, 80 °C; c, 4 -Bu 'QH,COCl , 
Et jN, D M F ; d, NaH, DMF, BrCHjCOOEt ; e, NaOH, aq. 1,4-dioxane, 
then HC1. An = 4-MeOC 6H,CO. 
in common solvents that we had to abandon this group. The 
4-ter/-butylbenzoyl group proved to be more rewarding; acid 5 8 
was easily obtained via intermediate 4 and used later. 
(A6-Anisoyladenin-9-yl)acetic acid 7 ' was prepared in 28% 
overall yield from adenine via the alkylation of compound 6 
(Scheme 2). An improved overall yield (40%) was obtained 
when tert-butyl bromoacetate was used for the alkylation 
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Scheme 2 Reagents and conditions: a, 1.5 equiv. AnCl, py, 100°C; b, 
NaH, DMF, BrCH 2COOMe; c, NaOH, then K H S 0 4 ; d, NaH, DMF, 
BrCHjCOOBu'; e, 50% (v/v) TFA-CH2C12 , (±)-l,4-dithiothreitol; f, 
NaH, DMF, BrCH2COOEt; g, 2.5 equiv. AnCI, py, 80 °C; h, NaOH, 
aq. MeOH, then HC1. 
instead of methyl bromoacetate followed by acidolysis. In 
an alternative approach ethyl (adenin-9-yl)acetate 8 ! was 
anisoylated with excess of anisoyl chloride and the resulting 
iV\A'6-dianisoylated derivative (not isolated) was subjected to 
partial hydrolysis to give acid 7 in an improved yield (70%; 
overall 45% from adenine). 
The substitution of guanine is notorious for giving N^IN1-
regioisomers.16 Although the 2-amino group is not really nucleo-
philic enough to interfere with many transformations, the poor 
solubility of unprotected guanine excludes its use in most reac-
tions. The application of /V7-acyl (acetyl, propionyl, isobutyryl, 
erc.)-protected derivatives increases the solubility but N1-
acylation alone cannot solve the fundamental problem of the 
selectivity of alkylation.16 Constraining guanine from its dom-
inant 6-lactam structure to lactim (enolate) form by different 
groups has a beneficial effect on the ratio of iV9/A,7-regio-
isomers. The most successful in this respect is the A'.A'-diphenyl-
carbamoyl protecting group17 which reportedly gives in some 
cases a 100:1 ratio in favour of the A^-regioisomer.18,19 To see 
how the introduction of this group alters the selectivity of 
alkylation, first 2-AMsobutyrylguanine 970 was alkylated with 
iert-butyl bromoacetate in the presence of sodium hydride to 
afford a nearly 1:1 ratio of V/W7-isomers (11 and 12, respect-
ively) in 74% yield (Scheme 3). The selection of the isobutyryl 
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Scheme 3 Reagents and conditions: a, (P r 'C0) 2 0 , DMF, 150°C; b, 
AC20, DMF, 100 °C; c, Ph 2NCOCl, EtNPr1 , , py; d, NaH, DMF, 0°C, 
BrCHjCOOBu' . Ibu = PdCO; Dpc = Ph2NCO. 
group was motivated by the fact that although its removal 
under basic conditions is more sluggish than that of other 
simple acyl groups (acetyl, propionyl)17,71 it confers steric 
hindrance on the 2-amino group and thus prevents unwanted 
alkylation/glycosylation on it.19 
Next the A'.A'-diphenylcarbamoyl derivative 1019,77 was 
chosen for alkylation studies under different conditions. Its 
transformation with tert-butyl glycolate73 in the Mitsunobu 
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Scheme 4 Reagents and conditions: a, DIAD, Ph5P, THF, HOCH 2 -
COOBu'; b, DIAD, 4-Me2NC6H4PPh2 , THF, HOCH 2 COOBu' ; c, 
DIAD, BujP, THF, HOCH 2COOBu' ; d, NaH, - 2 0 °C, DMF, BrCH2-
COOBu'; e, 8% (v/v) TFA-CH2C12, 1,3-(MeO)2C6H4, 0°C, 18 h; f, 
BrCH2COOMe, EtNPr'2 , D M F ; g, NaOH, aq. 1,4-dioxane-MeOH, 
then HC1. 
reaction74,75 provided the product (13, Scheme 4) with good 
regioselectivity; however, its purification was very difficult and 
it was contaminated with significant amounts of triphenyl-
phosphine oxide. (4-Dimethylaminophenyl)diphenylphos-
phine,76,77 claimed to give a phosphine oxide which can be 
removed by acidic extraction,78 proved to be unsatisfactory 
since the product was still contaminated with the corresponding 
phosphine oxide. Tributylphosphine, the oxide of which is 
water-soluble, gave a cleaner product but the yield was low 
(36%). In the next experiments sodium hydride-mediated 
alkylation with tert-butyl bromoacetate was used to obtain the 
desired compound. We noticed that at ambient temperature the 
relative proportion of A'7-regioisomer was relatively high, while 
lowering the temperature favoured the formation of the desired 
Af9-regioisomer. At —20 °C a clean reaction gave negligible 
amounts of the /W-isomer but the yield of A^-isomer was still 
low (40%). Acidolysis of ester 13 in dilute TFA-CH2C12 (0 °C; 
18 h) removed the A'.A-diphenylcarbamoyl (Dpc) group with-
out affecting the tert-butyl ester functionality ( > 11). Albeit 
there is some evidence for the lability of this group in 50% (v/v) 
TFA-CH2C128 or in the presence of Lewis acids79 it was surpris-
ing that the Dpc group was more sensitive towards acid than 
was the teri-butyl group. The latter was expected to cleave 
under similar conditions.14,30 
The application of N, A-diisopropylethylamine as a hindered 
base and methyl bromoacetate8 to circumvent premature cleav-
age of the Dpc group in the subsequent hydrolysis gave a 71% 
yield of the product 14, of which 58% was available without 
chromatography, along with 15% of the A7-isomer 15. Basic 
hydrolysis of ester 14 led to acid 16 in a clean transformation. 
The surprisingly high yield of the unwanted isomer 15 in the 
first reaction underlines the fact that even the sterically hin-
dered Dpc protecting group is not sufficient to steer the reaction 
to complete regioselectivity. Thus the claim that the use of the 
Dpc group has solved the historic problem of regioselective N9 -
substitution of guanine18,19 seems to be restricted to the realm 
of glycosylation reactions, while alkylation transformations 
require further experimentation. 
The coupling of nucleobase-substituted acetic acids 1, 5, 7, 
16 with the backbone unit 179 under standard peptide-coupling 
conditions afforded the PNA esters 18-21 which were sub-
sequently acidolysed (TFA in dichloromethane) to give the 
PNA monomers 22-25 (Scheme 5). As expected from our pre-
vious experience (13 > 11, Scheme 4) in the latter reaction 
the Dpc protecting group was removed along with the /er/-butyl 
group. It is clear that in this final deprotection step the protect-
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Scheme 5 Reagents and conditions', a, HBTU, HOBt, DMF, EtNPr'2; 
b, 17-43% (v/v)TFA-CH 2Cl 2 , l ,3-(MeO)2C sH,. 
ing groups of ester 21 (Fmoc, Ibu, Dpc, Bu') are not completely 
orthogonal and further research is required. Although the pres-
ence of the Dpc group is not essential in oligomer synthesis, it 
may confer better solubility on the guanine subunits. 
UV spectroscopy is often used to locate substituents on 
nucleobases. However, this technique is not reliable in the case 
of guanines especially if only one regioisomer is available." 
Moreover, there are no data on the influence of lactam/lactim 
tautomerism of guanines on UV properties. Indeed, the UV 
spectra of A^/V'-regioisomers 11/12 (lactams) and 14/15 
(lactims), respectively, in buffered ethanolic solutions (pH 0, 
6 and 13) revealed that there are no significant differences 
which would justify the assignment based solely on UV data. 
Therefore the site of alkylation in guanine derivatives 13-15, 
2632 was established in 2D NMR (HMQC33,34 and HMBC35,36) 
experiments. 
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Scrutinizing the l3C N M R chemical-shift parameters of 
compounds 11-16, 21, 25, 26 (Table 1) and a further 45 M/N1-
substituted guanines19,37-39 (altogether 54 compounds) show 
that ¿c.5 is the most sensitive to the TV9/TV7-substitution pattern 
(Fig. 1, N9: 113.75-123.70 ppm; /V7: 104.56-115.09 ppm; for 
regioisomers the difference [ A)c_5 = SC^(N9) - <5C.S(A'7)] is 7.86-
9.82 ppm), insensitive to the lactam/lactim tautomerism (data 
not shown) and this signal alone can be of diagnostic value, 
especially if data for both regioisomers are available. However, 
due to the overlapping of chemical-shift ranges for regioisomers 
this parameter might not be sufficient for unambiguous 
assignment. Kjellberg and Johansson37 suggested that <5C.,., <SC_5 
and <5C_8 could be used to differentiate Ar9/A'7-substituted 
guanines. This was also corroborated, in part, by our findings; 
however, some further tendencies were also observed. The util-
ity of differential parameters a = Sc., - b = Sc_$ - <5C.5) 
c = ¿c-s ~ <5C-r> (Fig- 1) has been assessed and the following 
conclusions could be drawn: 
1. The parameter a distinctly differs for the regioisomers {TV9: 
28.20-35.41 ppm; TV7: 41.35-54.25 ppm; for regioisomers the 
difference [Aa = «(TV9) - ^TV7)] is -9 .93 to -20.53 ppm}, 
shows little variation for lactam/lactim tautomerism (data not 
shown) and presents no overlapping ranges. The diagnostic 
value of this observation is slightly diminished since <5C.4 usually 
cannot be simply identified without having recourse to more 
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Fig. 1 13C N M R chemical-shift parameters of TV/TV-substituted 
guanines. 
sophisticated assignment techniques (selective INEPT, HMQC, 
HMBC, etc.). 
2. The parameter b shows similar characteristics {TV9: 16.10— 
26.91 ppm; TV7: 29.70^41.17 ppm; for regioisomers the differ-
ence [A = 6(TV9) = ¿(TV7)] is -11.68 to -16.15 ppm} and its utility 
is further enhanced by the fact that Sc.s is unmistakable 
among the skeletal carbons and <5C_8 can simply be located in a 
./-modulated spin-echo experiment. 
3. The parameter c can be clustered according to the nature 
of attached substituent rather than lactam/lactim tautomerism 
and it gives useful values for glycosylated derivatives {TV9: 
33.38-35.81 ppm; TV7: 16.30-23.38 ppm; for regioisomers the 
difference [Ac = c(N9) - c(A'7)] is 10.61-12.79 ppm} while for 
(cyclo)alkylated compounds it is of less use {TV9: 53.40-83.45 
ppm; TV7: 54.57—71.15 ppm; for regioisomers the difference 
[Ac = eiTV9) — c(TV7)] is 10.68-13.35 ppm). The identification 
of (5C4., involved in this parameter, often requires more sophisti-
cated techniques. 
As a conclusion it can be seen that the values a, b [both for 
(cyclo)alkyl and glycosylated derivatives] and c (for glyco-
sylated derivatives) are useful for characterizing the A /^TV7-
substitution pattern of guanines. From a practical point of view 
the parameter b is the most convenient one for the reasons 
explained above. It is noteworthy that<5c_5 (118.81 ppm) and the 
parameters a (35.38 ppm) and b (26.06 ppm) for compound 
1019 are in good agreement with those for TV-substituted 
derivatives, suggesting that its dominant tautomer is 9H in 
DMSO-d6 solution. 
Further studies relating to the application of the above 
monomers in the preparation of PNA oligomers and our quest 
for novel combinations of protecting groups are in progress and 
will be reported in due time. 
Experimental 
General 
The following abbreviations are employed: diisopropyl azodi-
carboxylate (DIAD); TV,TV-diisopropylethylamine (DIPEA); 
2-(l//-benzotriazol-l-yl)-l ,1,3,3-tetramethyluronium hexa-
fluorophosphate (HBTU); 1-hydroxybenzotriazole (HOBt); 
trifluoroacetic acid (TFA). Chemicals were purchased from 
Aldrich or Fluka. Sodium hydride refers to a 55% suspension in 
mineral oil. Anhydrous solvents were prepared as described.40 
Light petroleum refers to the fraction with distillation range 
40-60 °C. Thymine derivatives 1, 18 and 22 were prepared 
using the procedure of Thomson et al.9 TV7-Benzylguanine 
hydrochloride2 6 32 was prepared for comparison of its l3C NMR 
parameters with those of other guanine derivatives (see Table 
1). Organic solutions were dried using magnesium sulfate and 
evaporated in Biichi rotary evaporators. TLC: Kieselgel 60 F254 
(Merck), visualization: UV light. Column chromatography: 
Kieselgel 60 (0.063-0.200 mm, Merck). Mp: Electrothermal 
IA 8103 apparatus. Elemental analysis: Perkin-Elmer CHN 
J. Chem. Soc., Perkin Trans. I, 2000, 19-26 21 
analyzer model 2400. UV: PE Lambda 10 spectrometer, X ^ l 
nm Og «), sh: shoulder. IR: Bio-Rad FTS-60A (KBr pellets, » J 
cm'1; s, strong; m, medium; w, weak). NMR: Broker Avance 
DRX 400 and 500 spectrometers ('H: 400.13 MHz and 500.13 
MHz; , JC: 100.62 MHz and 125.76 MHz, respectively), 
DMSO-d« solutions, <5 (ppm), J (Hz). Spectral patterns: s, sing-
let; d, doublet; dd, double doublet; t, triplet; m, multiplet; br, 
broad; deut, deuterable. The superscripts *, # denote inter-
changeable assignments. For the 2D experiments (HMQC, 
HMBC) the standard Broker software packages (INV4GSSW, 
INV4GSLRNDSW) were applied. For 1JC NMR data of guan-
ine derivatives see Table 1. Mass spectrometry: Finnigan MAT 
TSQ 7000, electrospray (ESI) and atmospheric pressure chem-
ical ionization (APCI) techniques. IUPAC names: AutoNom™ 
2.1 (as implemented in ChemDraw® 5.0). Statistical analysis of 
13C NMR chemical-shift parameters of guanine derivatives 
(Fig. 1): Corel® Quattro® Pro 8.0, @ functions and SigmaPlot 
4.01. Details are available upon request. 
[4-(4-Methoxybenzoylamino)-2-oxo-l ,2-dihydropyrimidin-l -
yljacetic add 3 
Cytosine (1.11 g, 10.0 mmol) suspended in pyridine (50 mL) 
was stirred at room temperature while 4-methoxybenzoyl chlor-
ide (2.56 g, 15.0 mmol) was added and the reaction mixture was 
stirred in an oil-bath at 80 °C. The cytosine rapidly dissolved, 
and then the product precipitated from the solution. After 2 h 
the mixture was evaporated in vacuo and coevaporated with 
methanol (2x). The residue was suspended in methanol and the 
mixture was filtered to afford compound 3 (2.28 g, 93%) as a 
white powder, mp > 260 °C. The product [4-methoxy-A/-(2-oxo-
l,2-dihydropyrimidin-4-yl)benzamide, 2] was insoluble in 
practically all solvents, therefore it was used without further 
purification; R, 0.58 (CH2Cl2-MeOH 8:2); 2„,[0.20% (v/v) 
TFA in EtOH]/nm 216 Og s 4.00), 276 (4.35); v j c m " 1 3276w, 
3150w, 3073w, 2994w, 2846w, 1714s, 1692s, 1621m, 1609m, 
1578m, 1497s, 1406w, 1260s, 1189m, 801m. 
The majority (2.20 g, 8.97 mmol) of this substance was sus-
pended in anhydrous DMF (25 mL), anhydrous K 2C0 3 (1.24 g, 
8.97 mmol) and methyl bromoacetate (0.86 mL, 8.97 mmol) 
were added and the mixture was stirred for 24 h. The reaction 
mixture was filtered, washed with DMF and the filtrate was 
evaporated. Water (9 mL) and 4 M HC1 (0.4 mL) were added to 
the residue and stirred for 15 min. The ester was filtered off and 
then added to a mixture of aq. 2 M NaOH (6.5 mL, 13.0 mmol) 
and water (12 mL) and the reaction mixture was sonicated. The 
substance dissolved and after 30 min no starting material was 
present (TLC). The reaction mixture was acidified with 4 M 
HC1 (3.6 mL, 14.4 mmol) and the precipitated substance was 
filtered off. Purification of the crude product (2.94 g) was 
attempted by recrystallization from methanol. 1 L of solvent 
was not enough to dissolve the above amount, and so 0.45 g was 
filtered off to give a white powder, TLC: single spot, mp 220 °C 
(darkens), 239 °C (decomp.). From the methanolic solution a 
second crop (0.86 g) was obtained as a white powder, TLC: 
single spot, mp 166 °C (darkens), 227 °C (decomp.). Overall 
yield: 1.31 g (48%); R, 0.58 (MeCN-MeOH-AcOH 4:1:1) 
(Found: C, 55.5; H, 4.2; N, 13.7. Calc. for C14H13N305: C, 55.45; 
H, 4.3; N, 13.9%); 2„„(EtOH)/nm 208 Og e 4.58), 252 (4.55), 287 
(4.27); v ^ / c m ' 1 3147w, 3076w, 1711s, 1631m, 1615w, 1503m, 
1419w, 1251m, 1183m, 755w; <5„ (400 MHz) 3.84 (3 H, s, 
OCHj), 4.56 (2 H, s, CH2), 7.04 and 8.03 (2 x 2 H, 2 x d, 78.9, 
ArH), 7.30(1 H,d,77.2 , H-5*), 8.08(1 H , d , / 7 . 2 , H-6*), 11.03 
(1 H, br s, deut, OH*), 11.97 (1 H, br s, deut, NH*); mlz (ESI) 
304 (44%, [M + H]+). This compound was mentioned by 
Breipohl et al.* but not described in detail. 
[6-(4-Methoxybenzoylamino)purin-9-yl]acetic acid 7 
A. Alkylation of [6-(4-methoxybenzoyIamino)purine] and sub-
sequent addolysis. To [6-(4-methoxybenzoylamino)purine] 6 7 
(6.47 g, 24.0 mmol) suspended in anhydrous DMF (120 mL) 
was added sodium hydride (1.05 g, 24.0 mmol) in portions and 
the mixture was stirred at room temperature for 30 min. tert-
Butyl bromoacetate (3.9 mL, 26.4 mmol) was added dropwise 
and stirring was continued for 2 h. The mixture was evaporated 
in vacuo and the residue was suspended in a mixture of 
water (200 mL) and dichloromethane (200 mL). The resulting 
precipitate was filtered off and dried (5.66 g, 61%). The major-
ity (5.50 g, 14.3 mmol) of this substance was stirred with 50% 
(v/v) TFA in dichloromethane (40 mL) and (±)l,4-dithio-
threitol (0.20 g, 1.3 mmol) at room temperature for 4 h. 
The solution was evaporated in vacuo and the residue was 
coevaporated with EtOAc (5x). The residue was dissolved 
in 5% (w/v) aq. NaHC0 3 (150 mL), filtered and acidified with 
10% (w/v) aq. NaHS0 4 (100 mL). The precipitated solid was 
filtered off (4.11 g, 88%), to give 7 mp 213 °C (darkens), 250 °C 
(decomp.). The characteristics (*H NMR and mass spectra) 
of this substance were in good agreement both with the pub-
lished values7 and with those of the substance prepared in 
procedure B. 
B. Controlled hydrolysis of a dianisoylated derivative. Ethyl 
(adenin-9-yl)acetate 8 s (4.42 g, 20 mmol) was suspended in 
anhydrous pyridine (50 mL), heated to 80 °C for 30 min, then 
cooled to room temperature. 4-Methoxybenzoyl chloride (8.53 
g, 50.0 mmol) was added in portions and the mixture was 
stirred for 18 h, then evaporated in vacuo and the residue was 
coevaporated with toluene (3x). The residue was dissolved in 
dichloromethane (70 mL), and the solution was washed with 
10% (w/v) citric acid (2 x 30 mL), dried and evaporated in 
vacuo. The crude product (14.96 g) was dissolved in warm 
ethanol (100 mL), cooled to room temperature, 2 M aq. NaOH 
(30 mL) was added, and the solution was left at room temper-
ature and checked from time to time by TLC. After 175 min 
more aq. NaOH (5 mL) was added. The reaction was stopped 
after 4 h by addition of 1 M HC1 (35 mL), pH «5, and the 
solution was evaporated in vacuo. The crude product was 
recrystallized from methanol (1 L) to afford a white powder 
(4.58 g, 70%), mp 215 °C (darkens), 254 °C (decomp.) pit.,7 
222-223 °C (decomp.)]. The 'H NMR and mass spectra 
of this compound were in good agreement with the published 
values.7 
(2-Isobutyrylamino-6-oxo-l,6-dihydropurin-9-yl)acetic acid tert-
butyl ester 11 and (2-isobutyrylamino-6-oxo-l,6-dihydropurin-7-
yl)acetic add (erf-butyl es t« 12 
A/-(6-Oxo-6,9-dihydro-l/7-purin-2-yl)isobutyramide9l9,M (1.11 
g, 5.0 mmol) was suspended in anhydrous DMF and the mix-
ture was chilled to 0 °C. Sodium hydride (0.36 g, 8.25 mmol) 
was added and the mixture was stirred at 0 °C for 30 min. tert-
Butyl bromoacetate (0.81 mL, 5.5 mmol) was added and the 
reaction was stopped after 2 h by addition of a small amount of 
solid C0 2 and methanol (2 mL). The reaction mixture was 
evaporated in vacuo and the residue was chromatographed 
using 0-5% (v/v) methanol in dichloromethane. Eluted first was 
the less polar A/7-isomer 12, (0.43 g, 26%), second a mixture 
(in »1:1 ratio as judged by TLC and 'H NMR) of A/7- and 
A^-isomer (0.24 g, 14%), and third the pure A/'-isomer 11 (0.56 
g, 34%). 
Ester 11: white powder, mp 204 °C (decomp., from EtOH); R, 
0.13 (CH2Cl2-MeOH 95:5) (Found: C, 53.9; H, 6.4; N, 21.1. 
Calc. for C15H2IN504: C, 53.7; H, 6.3; N, 20.9%); 2mM[50% (v/v) 
1 M HC1 in EtOH, pH 0]/nm 206 Og e 4.26), 265 (4.23); 2a„[50% 
(v/v) phosphate buffer in EtOH, pH 6]/nm 260 Qg e 4.17), 282sh 
(4.02); A„,[50% (v/v) 0.1 M NaOH in EtOH, pH 13]/nm 216 Og e 
4.39), 263 (4.06); v^/cm'13151w, 2980w, 2932w, 1753s, 1698m, 
1673s, 1614m, 1562m, 1549m, 1483w, 1411m, 1233m, 1154m, 
1143m, 795w; <5„ (500 MHz) 1.11 [6 H, d, J 6.8, (C/73)2CH], 
1.40 (9 H, s, Bu1), 2.78 [1 H, pseudoquintet, (CH^CH], 4.88 
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Table 1 1 !C N M R chemical shifts of guanine derivatives (S, ppm)" 
Compd. Subst. C-2 C-4 C-5 C-6 C-8 Other carbons 
1 0 « 152.34 154.19 118.81 157.41 144.87 irrelevant 
11" A 9 148.49 155.17 119.98 149.30 140.72 19.22 [(CHJ)2CH], 28.03 [(CHJ)JC], 35.01 [ ( C H ^ C H ] , 45.17 (CHjCOO), 
82.69 [ ( C H j ) j q , 167.03 (COOBu'), 180.56 (Pr'CO) 
12 A 7 147.55 157.20 112.08 152.95 144.50 19.23 [(CHJ)2CH], 28.00 [(CH3)JC], 35.06 [(CHJ)JCH], 48.26 (CHjCOO), 
82.36 [(CHJ)JC], 167.20 (COOBu1), 180.32 (Pr'CO) 
1 3 " A 9 153.24 155.88 120.47 155.95 147.01 20.08 [(CHJLCH], 28.52 [(CHJ)3C], 35.18 [(CH3)jCH], 45.82 (CHjCOO), 
83.40 [ ( O - L h q , 127.76, 128.15, 130.26 (arom. Cs), 142.51 (arom. quater-
nary Q , 151.03 (OCON), 167.33 (COOBu'), 175.97 (Pr'CO) 
1 4 ' / A 9 153.29 155.91 120.51 155.91 146.90 20.08 [(CHjjjCH], 35.25 [(CHOjCH], 45.14 (CH2COO), 53.48 (CH,0 ) , 
127.79, 128.14, 130.26 (arom. Cs), 142.51 (arom, quaternary Q , 151.03 
(OCON), 168.85 (COOMe), 175.90 (Pr'CO) 
15/ A 7 149.53 164.63 112.19 141.28 150.44 19.20 [ ( C H I C H I , 34.26 [(CHj)jCH], 47.50 (CHjCOO), 52.50 (CHjO), 
128.91, 129.04, 129.36 (arom. Cs), 141.28 (arom. quaternary Q , 152.02 
A 9 
(OCON), 167.77 (COOMe), 174.94 (Pr'CO) 
16 ' 152.19 154.81 119.62 155.03 146.50 19.08 [(CHJ)JCH], 34.22 [(CH3)2CH], 66.22 (CHjCOO), 126.90, 129.17, 
129.37, 129.90 (arom. Cs), 141.49 (arom. quaternary C), 150.07 (OCON), 
A 9 
174.93 (Pr'CO, COOH) 
2 1 " 152.01 154.72 119.40 155.05 146.31 18.98 [(CHJ)JCH], 27.47/27.50 [(CHJ)3C], 34.17 [(CH3)2CH], 46.56 
(OCHjCH), 43.73/43.99, 47.09, 48.76,49.96 (4 x CH2), 65.28 (OCH3CH), 
80.88/81.98 [(CHJ)JQ, 119.88, 124.79/124.88, 126.81/126.85, 126.95, 
127.40, 128.71, 129.20 (arom. Cs), 140.54, 141.45, 143.61/143.65 (arom. 
quaternary C), 150.00 (OCON), 155.13, 155.95/156.21, 166.24/166.74, 
167.69/168.32 (4 x CO), 175.00 (Pr'CO) 
2 5 " A 9 147.79, 
147.82 
149.16, 
149.24 
119.49 154.79 140.45 18.76 [(CHJ)JCH], 34.58 [ ( C H ^ C H ] , 46.66 (OCHjCH), 43.86/44.00, 
46.85/46.97, 47.76, 49.11 (4 x CHj) , 65.43 (OCHjCH), 120.01/120.04, 
124.94/125.01, 126.95, 127.53 (arom. Cs), 140.64/140.68, 143.76/143.78 
(arom. quaternary Q , 156.07/156.30, 166.37/166.91, 170.28/170.72 
2 6 « ' 
(3 x CO), 180.05 (Pr'CO, COOH) 
A 7 154.95 151.46 108.07 153.92 141.06 51.09 (CHj), 128.70, 129.15,129.62 (arom. Cs), 136.38 (arom. quaternary 
Q 
" In DMSO-d6 ; 125.76 MHz; /-modulated spin-echo experiments; for guanine numbering see ester 11, Scheme 3 . ' Ref. 19 . ' The C-4, C-5, C-6, C-8 
signals were observed only after adding trifluoroacetic acid. "The assignment of signals corresponding to C-2 and C-6 carbons is tentative. ' The 
assignment of signals corresponding to C-4 and C-6 carbons is tentative. ' Assignment based on H M Q C and H M B C experiments. ' Some signals 
were doubled due to the presence of rotamers. * .V-Benzylguanine hydrochloride, prepared according to Bridson el al.'2 
(2 H, s, CH2COO), 7.95 (1 H, s, H-8), 11.65 (1 H, br s, deut, 
NH), 12.10 (1 H, br s, deut, NH); mlz (ESI) 693 (20%, 
[2M + Na]+), 671 (55, [2M + H]+), 336 (100, [M + H]+). 
Ester 12: white powder, mp 202.5 °C (decomp., from EtOH); 
R, 0.19 (CH2Cl2-MeOH 95:5) (Found: C, 53.65; H, 6.15; N, 
21.1%); /m„[50% (v/v) 1 M HC1 in EtOH, pH 0]/nm 206 (lg s 
4.24), 263 (4.20); /ma,[50% (v/v) phosphate buffer in EtOH, pH 
6]/nm 221 (lg e 4.24), 265 (4.11), 282sh (3.98); imal[50% (v/v) 0.1 
M NaOH in EtOH, pH 13]/nm 224 (lg s 4.31), 269 (4.01); v ^ / 
cm - 1 3240w, 2981w, 2937w, 1741m, 1695s, 1677s, 1604s, 1535w, 
1421 w, 1390m, 1370m, 1238m, 1160m, 747w; <S„ (500 M Hz) 1.11 
[6 H, d, 76.8, (Ci/3)2CH], 1.39 (9 H, s, Bu1), 2.73 [1 H, pseudo-
quintet, (CH3)2CA], 5.07 (2 H, s, CH2COO), 8.11 (1 H, S, H-8), 
11.55 (1 H, br s, deut, NH), 12.14 (1 H, br s, deut, NH); mlz 
(ESI) 693 (40%, [2M + Na]+), 671 (25, [2M + H]+), 358 (27, 
[M + Na]+), 336 (100, [M + H]+). 
[6-DiphenyIcarbanioyloxy-2-(isobutyrylamino)purin-9-yl]acetic 
acid ferf-butyl ester 13 
A. Mitsunobu reaction, general procedure. Compound 1019,22 
(1.00 g, 2.40 mmol) was suspended in anhydrous THF (50 mL) 
and the mixture was refluxed for 20 min to achieve partial dis-
solution of the starting material.20 The suspension was cooled 
to room temperature, rerr-butyl glycolate23 (0.40 g, 3.0 mmol), 
the appropriate phosphine (3.19 mmol) and DIAD (0.62 mL, 
3.19 mmol)-were added dropwise, and the mixture was stirred at 
room temperature. The reaction mixture completely dissolved 
and became yellow coloured. After completion of the reaction 
(TLC) the solution was evaporated in vacuo and the residue was 
subjected to chromatographic purification. 
Al. With triphenylphosphine.—Reaction time: 4 h at room 
temperature. Chromatography: 50-70% (v/v) ethyl acetate in 
light petroleum. Eluted first was the product 13 (0.31 g), slightly 
contaminated with triphenylphosphine oxide. Further fractions 
were also obtained containing varying proportions of the 
product and triphenylphosphine oxide. The different, partly 
crystalline fractions were triturated with methanol upon which 
the product crystallized. This was filtered off and washed with 
light petroleum. The cleanest product (0.40 g, 31%), a white 
powder, melted at 183.2-185.5 °C. A further crystalline crop 
(0.39 g) containing the product and triphenylphosphine oxide 
(TLC) was also obtained; R, 0.50 (CH2Cl2-MeOH 95:5) 
(Found: C, 63.5; H, 5.5; N, 15.7. Calc. for C ^ H ^ O , : C, 63.4; 
H, 5.7; N, 15.8%); /„^(EtOHVnm 205 (lg a 4.60), 229 (4.53), 
258sh (4.15), 279 (4.08); 7 ^ / c m " 1 3462w, 3346w, 2979w, 2934w, 
1738s, 1715m, 1624m, 1587m, 1524m, 1449m, 1411m, 1305m, 
1240m, 1187s, 1164s, 1056m, 758w, 700m; <5H (500 MHz) 1.09 
[6 H, d, 76.8, (C//3)2CH], 1.43 (9 H, s, Bu1), 2.87 [1 H, pseudo-
quintet, J 6.8, (CH3)2C//j, 5.03 (2 H, s, CH2), 7.29-7.53 (10 H, 
m, ArH), 8.45 (1 H, s, H-8), 10.69 (1 H, br s, deut, NH); mlz 
(ESI) 557 (8%, [2Ph3PO + H]+), 531 (100, [M + H]+). 
A2. With 4-(dimethylamino)phenyl(diphenyl) phosphine.26,27— 
Reaction time: 2.5 h at 0 °C. Work-up: the crude product was 
dissolved in dichloromethane (50 mL) and extracted succes-
sively with 4 M HC1 (3 x 25 mL) and with 5% (w/v) aq. 
NaHCO, (50 mL). TLC revealed that most of the 4-(di-
methylamino)phenyl(diphenyl)phosphine oxide remained in the 
organic phase. The organic phase was dried, and purified 
by column chromatography using 0-1% (v/v) methanol in 
dichloromethane. Methanolic trituration and filtration (light 
petroleum) afforded the product (0.42 g, 33%), mp 182.5-
185.0 °C. The IR, 'H NMR and mass spectra of this compound 
were in good agreement with those of the substance obtained 
in procedure Al. 
A3. With tributylphosphine.—Reaction time: 1.5 h at 0 °C. 
Work-up: the crude product was dissolved in dichloromethane 
(50 mL) and extracted with water (3 x 25 mL) to remove 
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the tributylphosphine oxide. Chromatography: 0-1.5% (v/v) 
methanol in dichloromethane. Methanolic trituration and 
filtration (light petroleum) afforded the product (0.46 g, 36%), 
mp 182.2-184.8 °C. The IR, 'H NMR and mass spectra of this 
compound were in good agreement with those of the substance 
obtained in procedure Al. 
B. Low-temperature, sodium hydride-mediated alkylation. To 
compound 1019,22 (1.40 g, 3.36 mmol) suspended in anhydrous 
DMF (20 mL) was added sodium hydride (0.16 g, 3.70 mmol) at 
room temperature. After 30 min the reaction mixture was 
chilled to - 2 0 °C and maintained at this temperature, tert-
Butyl bromoacetate (0.60 mL, 4.0 mmol) was added dropwise. 
After 2 h the reaction was stopped by addition of a small 
amount of solid C0 2 and methanol, and the mixture was 
evaporated in vacuo and coevaporated with toluene (2x). The 
residue was dissolved in a mixture of water and dichloro-
methane (20 mL each). The aqueous phase was extracted with 
dichloromethane ( 3 x 1 5 mL), and the combined organic 
phases were dried, and evaporated in vacuo. Chromatography: 
0-1% (v/v) methanol in dichloromethane. Methanolic tritur-
ation and subsequent crystallization from methanol (15 mL) 
afforded the product (0.70 g, 40%) as a white powder, mp 
183.1-184.5 °C. The IR, 'H N M R and mass spectra of this 
compound were in good agreement with those of the substance 
obtained in procedure Al. 
Hydrolysis of [6-diphenyIcarbamoyloxy-2-(isobutyrylamino)-
purin-9-yl]acctic acid tot-butyl ester (13 > 11) 
To ester 13 (0.210 g, 0.38 mmol) dissolved in anhydrous 
dichloromethane (6 mL) were added 1,3-dimethoxybenzene 
(0.070 mL, 0.53 mmol) and TFA (0.50 mL, 6.5 mmol) at 0 °C 
and the mixture was stirred for 18 h. The reaction mixture was 
diluted with dichloromethane (20 mL), and extracted with satd. 
aq. NaHC0 3 solution (3 x 10 mL) to remove the excess of acid. 
Chromatography: 0-10% (v/v) methanol in dichloromethane to 
give the lactam 11 (0.069 g, 55%) as an amorphous foam. The 
IR, 'H N M R and mass spectra of this product were in good 
agreement with those of the substance obtained in a previous 
experiment {vide supra). 
[6-Diphenylcarbamoyloxy-2-(isobutyrylaniino)purin-9-yl]acetic 
add methyl ester 14 and [6-diphenylcarbamoyloxy-2-(isobutyryl-
amino)purin-7-yl]acetic acid methyl ester 15 {cf. ref. 8) 
To compound 1019,22 (3.53 g, 8.47 mmol) suspended in 
anhydrous DMF (40 mL) was added DIPEA (2.87 mL, 16.74 
mmol) and the mixture was briefly heated to 80 °C until a clear 
solution was obtained (10 min). The mixture was cooled to 
room temperature, methyl bromoacetate (0.87 mL, 9.32 mmol) 
was added, and the mixture was stirred for 20 h. The reaction 
mixture was evaporated in vacuo and the residue was coevapo-
rated with methanol (3x). The partly crystalline material was 
suspended in methanol (40 mL) and added dropwise to water 
(120 mL) with vigorous stirring. The precipitate was filtered off 
(3.99 g, 96%) and »crystallized from EtOAc (190 mL) to afford 
the title products (2.01 g, 49%), mp 167.0-168.4 °C; from the 
mother liquor was obtained a further crop (0.37 g, 9%), mp 
168.0-170.4 °C. The mother liquor was evaporated and chrom-
atographed by using 1-4% (v/v) methanol in dichloromethane. 
Eluted first was ester 14 (0.54 g, 13%) then its regjoisomer 15 
(0.60 g, 15%). Overall yield of 14:2.92 g, 71%. 
Ester 14: white powder, mp 170.0-171.4 °C (from EtOAc); R, 
0.37 (CHjClj-MeOH 95:5) (Found: C, 61.35; H, 5.1; N, 17.4. 
Calc. for C j j H 1 4 N 6 0 5 : C , 61.5; H, 4.95; N, 17.2%); 2^ (50% 
(v/v) 1 M HC1 in EtOH, pH 0]/nm 207 Og e 4.50), 226 (4.53), 
253sh (4.17), 279 (4.07); 2„„[50% (v/v) phosphate buffer in 
EtOH, pH 6]/nm 227 (lg e 4.54), 259sh (4.14), 277 (4.08); 
¿„„[50% (v/v) 0.1 M NaOH in EtOH, pH 13]/nm 230 (lge 4.45), 
276 (4.03); v ^ c m " 1 3295w, 2996w, 2956w, 1756m, 1726s, 
1681s, 1631m, 1599m, 1491m, 1384m, 1340s, 1233s, 1223s, 
1192m, 1063m, 789w, 758w, 704w; <$„ (500 MHz) 1.08 [6 H, d, 
J 6.8, (C//j)jCH], 2.83 [1 H, pseudoquintet, J 6.8, (CH3)2Ctf ], 
3.73 (3 H, s, CH}), 5.15 (2 H, s, CHj), 7.31-7.49 (10 H, m, 
ArH), 8.43 (1 H, s, H-8), 10.64 (1 H, br s, deut, NH); mlz (ESI) 
511 (25%, [M + Na]+), 489 (100, [M + H]+). 
Ester 15: amorphous foam; R, 0.35 (CH2Clj-MeOH 9:1) 
(Found: C, 61.3; H, 5.1; N, 17.0); 2„,[50% (v/v) 1 M HC1 in 
EtOH, pH 0]/nm 207 (lg e 4.59), 227 (4.56), 252sh (4.26), 283 
(4.09); 2m«,[50% (v/v) phosphate buffer in EtOH, pH 6]/nm 230 
(lg £ 4.61), 256sh (4.17), 282 (4.02); >L„[50% (v/v) 0.1 M NaOH 
in EtOH, pH 13]/nm 229 (lg e 4.53), 287sh (3.90); v j c m " 1 
3438w, 2972w, 1753s, 1707m, 1639m, 1592w, 1493s, 1445m, 
1301s, 1187s, 761m, 701m; <5„ (500 MHz) 1.11 [6 H, d, J 6.8, 
(C//3)2CH], 2.85 [1 H, pseudoquintet, J 6.8, (CH3)2C//], 3.56 
(3 H, s, CH3), 5.20 (2 H, s, CHj), 7.28-7.48 (10 H, m, ArH), 8.53 
(1 H, s, H-8), 10.57 (1 H, br s, deut, NH); mlz (ESI) 511 (40%, 
[M + Na]+), 489 (100, [M + H]+). 
[6-Diphenylcarbamoyloxy-2-(isobutyryIamino)purin-9-yl]acetic 
add 16 {cf. ref. 8) 
Ester 14 (2.24 g, 4.59 mmol) was suspended under sonication in 
a mixture of methanol (6 mL), 1,4-dioxane (24 mL) and water 
(12 mL). 1 M aq. NaOH (5 mL) was added and the mixture was 
stirred for 30 min. The pH of the mixture was brought to »6 by 
addition of 1 M HC1 and the organics were evaporated off in 
vacuo. The solution was diluted with water (120 mL) and acid-
ified to pH »3 by addition of 1 M HC1. The precipitate was 
filtered off, and washed with ice-water to give acid 16 (1.99 g, 
91%), white powder, mp 156 °C (decomp.). Attempted recrystal-
lization from EtOAc resulted in gel formation; i?f0.40 (MeCN-
MeOH-AcOH 8:1:1) (Found: C, 60.5; H, 4.4; N, 17.4. Calc. 
for CmHjjNjOj: C, 60.75; H, 4.7; N, 17.7%); ^ ( E t O H J / n m 
229 Og e 4.51), 260sh (4.11), 279 (4.06); v j a n " ' 3379w, 1723s, 
1627m, 1591m, 1522m, 1493m, 1441m, 1411m, 1307m, 1200s, 
1187s, 760w, 701m; <5„ (500 MHz) 1.09 [6 H, s, (C//3)2CH], 2.83 
[1 H, m, (CHj)2C/f], 5.05 (2 H, s, CHJ , 7.29-7.50 (10 H, m, 
ArH), 8.46 (1 H, s, H-8), 10.65 (1 H, br s, deut, NH); mlz [ESI 
(CHC13 + MeOH)], 971 (8%, [2M + Na]+), 514 (8, [M + K]+), 
497 (20, [M + Na]+), 475 (100, [M + H]+). 
Esters 19-21 
General procedure. To add 5,7 7 or 16 (2.0 mmol) dissolved in 
anhydrous DMF (20 mL) were added HOBt hydrate (0.61 g, 4.0 
mmol) and HBTU (1.52 g, 4.0 mmol). Meanwhile ester 179 
(1.95 g, 3.0 mmol for adds 5 ,7 and 1.30 g, 2.0 mmol for add 16) 
was suspended in dichloromethane (20/30 mL), extracted with 
satd. aq. NaHC0 3 (10 mL) and dried. The above dichloro-
methane solution of free 17 base and DIPEA (0.70 mL, 4.0 
mmol) were added after 5 min and the reaction mixture was 
stirred at room temperature. Work-up: after evaporation of the 
solution in vacuo, the residue was dissolved in dichloromethane 
(30 mL), extracted with 1 M HC1 ( 1 9 : 3 x 1 0 mL) or with satd. 
aq. NaHS0 4 (20: 5 x 10 mL), and washed successively with 
satd. aq. NaHCO} (25 mL) and brine (25 mL). In the case of 
21, after evaporation of the reaction mixture the residue was 
triturated with EtOAc (5 mL) and filtered, followed by crystal-
lization. The resulting crude products were purified chromato-
graphically (19,20) or by crystallization (21). 
( {2-[4-(4-tert-Butylbenzoylamino)-2-oxo-l,2-dihydropyrim-
idin-l-yl]acetyl}-[2-(9H-fluoren-9-ylmethoxycarbonylamino)-
ethyl]amino)acetic acid tert-butyl ester 19.—Reaction time: 20 
h at room temperature. Chromatography: 1-3% (v/v) methanol 
in dichloromethane, yield 0.99 g (70%), colourless oil. In a 
repeated experiment the extractive work-up was omitted and 
the crude product was triturated with methanol (2 mL) to yield 
a cleaner product (0.82 g, 58%), amorphous foam; Rt 0.49 
(CH2Cl2-MeOH 95:5) (Found: C, 67.6; H, 6.4; N, 9.7. Calc. for 
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C^H^NjO, : C, 67.8; H, 6.5; N, 9.9%); ^ ( E t O H V n m 205 Og e 
4.19), 265 (3.94), 288 (3.52), 300 (3.52); » J e m ' 1 3450m, 
3150w, 3070w, 2966w, 2936w, 1710s, 1670s, 1629m, 1563m, 
1492s, 1408w, 1367s, 1254s, 1156s, 1113s, 851 w, 759w, 740w; 
dH (500 MHz, retainers) 1.29 (9 H, s, Bu% 1.40 (9 H, s, Bu1), 
1.46 (2 H, s, CHJ , 3.23 (2 H, m, CHJ , 3.44 (2 H, m, CHj), 3.97 
(3 H, s, CHjO), 4.26 (1 H, m, CH), 4.68/4.90 (2 H, 2 s, CHJ , 
6.27 (1 H, s, H-5*), 7.34 (2 H, dd, 77.4 and 7.2, fluorenyl CH), 
7.41 (2 H, dd, 7 7.4 and 7.2, fluorenyl CH), 7.52 (2 H, d, 78.3, 
4-Bu'C67/4CO), 7.83 (2 H, d, 77.5, fluorenyl CH), 7.87 (2 H, d, 
7 7.5, fluorenyl CH), 7.98 (2 H, d, 7 8.3, 4-Bu'C6//4CO), 8.00 
(1 H, s, H-6*); mlz (ESI) 730 (78%, [M + Na]+), 708 (100, 
[M + H]+). 
([2-(9H-Fluoren-9-ylmethoxycarbonylamino)ethyl]-{2-[6-(4-
methoxybenzoylamino)purin-9-yl]acetyl}amino)acetic acid tert-
butyl ester 20.—Reaction time: 1.5 h at room temperature. 
Chromatography: 0-20% (v/v) EtOAc in methanol, yield 1.20 g 
(85%), amorphous foam; R, 0.42 (CH2Cl2-MeOH 95:5) 
(Found: C, 64.8; H, 5.4; N, 13.7. Calc. for Q g H ^ N A : C, 64.7; 
H, 5.6; N, 13.9%); ¿„ . (EtOHynm 206 Og e 4.78), 266 (4.41), 278 
(4.41), 289 (4.42), 300sh (4.32); v^/cm"13065w, 2980w, 2943w, 
1705m, 1670m, 1609m, 1586m, 1513w, 1458m, 1411w, 1252s, 
1157m, 845s, 762m, 743m; <5„ (500 MHz, rotamers) 1.32 (9 H, s, 
Bu"), 2.81 (2 H, s, CH2), 3.25 (2 H, m, CH2), 3.65 (2 H, m, CH2), 
3.94 (3 H, s, CHjO), 4.50 (3 H, m, CH, CHj), 5.25/5.44 (2 H, 2 s, 
CHJ , 7.16 (2 H, d, 78.7, anisoyl CH), 7.39 (2 H, dd, 77.4 and 
7.2, fluorenyl CH), 7.49 (2 H, dd, 7 7.4 and 7.2, fluorenyl CH), 
7.76 (2 H, d, 7 7.4, fluorenyl CH), 7.96 (2 H, d, 7 7.4, fluorenyl 
CH), 8.13 (2 H, d, 78.6, anisoyl CH), 8.40 (1 H, s, H-8*), 8.70 
(1 H, s, H-2*), 11.10 (1 H, br s, NH); mlz (ESI) 706 (100%, 
[M + H]+). 
( {2-[6-Diphenylcarbamoy!oxy-2-( isobutyrylamino)purin-9-
yl]acetyl}-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]-
amino) acetic acid tert-butyl ester 21.—Reaction time: 1.5 h at 
room temperature. The crude product was obtained as 
described above and was recrystallized from ethanol (750 
mL) to give a white powder (1.22 g, 40%), mp 209.0-209.5 °C 
(decomp.); R, 0.36 (CH2Cl2-MeOH 95:5) (Found: C, 66.3; H, 
5.5; N, 12.9. Calc. for C47H4iNgOs: C, 66.2; H, 5.7; N, 13.1%); 
/„„(EtOHVnm 221 Og « 4.57), 228 (4.53), 256 (4.39), 266sh 
(4.38), 279sh (4.27), 289sh (4.07), 300 (3.81); v j e m " 1 3302m, 
2979w, 1750m, 1732s, 1704s, 1656s, 1624w, 1591w, 1545m, 
1493w, 1450m, 1192s, 1156m, 1055m, 762m, 697w; <5„ (500 
MHz, rotamers) 1.06 [6 H, d, 76.2, (Ctf3)2CH], 1.35/1.47 (9 H, 
2 s, Bu"), 2.83 [1.3 H, m, (CHJ2CH, NH], 3.52 (4 H, m, partly 
shielded by the water signal, 2 x CHJ , 3.95 (1 H, s, CH), 4.19-
4.29 (2 H, m, CHJ , 4.32-4.35 (2 H, m, CHJ , 5.07/5.25 (2 H, 
2 x s, guanyl CHJ , 7.22-7.48 (14 H, m, 2 x Ph, fluorenyl 
CH), 7.64 (2 H, d, 77.3, fluorenyl CH), 7.86 (2 H, dd, 77.9 and 
7.9, fluorenyl CH), 8.30 (1 H, s, H-8), 10.57 (1 H, s, NH); mlz 
(ESI) 891 (1%, [M + K]+); 875 (5, [M + Na]+); 853 (100, 
[M + H]+). 
({2-[4-(4-fert-Butylbenzoylamino)-2-oxo-l,2-dihydropyriniidin-
l-yl]acetyl}-[2-(9//-fluoren-9-ylmethoxycarbonylamino)ethyl]-
aniino)acetic acid 23 
To ester 19 (0.40 g, 0.56 mmol) dissolved in dichloromethane 
(20 mL) was added 1,3-dimethoxybenzene (0.19 mL, 1.45 
mmol) followed by TFA (4.0 mL, 52.3 mmol) and the mixture 
was stirred for 6 h at room temperature. The solution was evap-
orated in vacuo, and the residue was coevaporated with 
acetonitrile (5x). The residue was triturated under diethyl ether, 
filtered and recrystallized from methanol (20 mL) to give a 
white powder (0.27 g, 73%), mp 197.4-199.0 °C (decomp.); R, 
0.86 (CH2Cl2-MeOH 6:4) (Found: C, 66.3; H, 5.7; N, 10.6. 
Calc. for CJSHMNJO,: C, 66.2; H, 5.9; N, 10.7%); 2„„(EtOH)/ 
nm 205 Og e 4.88), 265 (4.68), 289 (4.25), 300 (4.27); v j e m " 1 
3147w, 3067w, 2964w, 1708s, 1664s, 1610m, 1562m, 1490s, 
1409w, 1367m, 1255m, 1113w, 853w, 760w, 741 w; <5„ (500 MHz, 
rotamers) 1.34 (9 H, s, Bu1), 3.14/3.25 (1 H, 2 m, partly shielded 
by the water signal, CHJ , 3.38/3.47 (1.4 H, 2 m, partly shielded 
by the water signal, CHJ , 4.03/4.22 (2 H, 2 s, CHJ , 4.26 (1 H, 
m, CH), 4.31/4.36 (2 H, 2 d, 7 6.7, CHJ , 4.70/4.89 (2 H, 2 s, 
cytosinyl CHJ , 7.27/7.41 (1 H, 2 d, 7 7.5, H-5*), 7.33 (3 H, 
dd, 7 7.5 and 6.8, fluorenyl CH, NH), 7.42 (2 H, d, 7 6.8, fluor-
enyl CH), 7.53 (2 H, d, 7 8.4, 4-Bu'Q//4CO), 7.69 (2 H, dd, 
7 7.5 and 6.8, fluorenyl CH), 7.89 (2 H, d, 7 7.5, fluorenyl 
CH), 7.94 (1 H, d, 7 7.3, H-6*), 7.98 (2 H, dd, 7 2.7, 8.4, 
4 - B U ' C 6 / / 4 C O ) , 1 1 . 2 0 (1 H , b r s, N H * ) , 1 2 . 8 0 (1 H , b r s, O H * ) ; 
mlz (ESI) 652 (100%, [M + H]+). 
([2-(97/-Fluoren-9-ylniethoxycarbonylamino)ethyl]-{2-[6-(4-
rnethoxybenzoylamino)piirin-9-yl]acetyl}aimno)acetic acid 24 
To ester 20 (0.92 g, 1.30 mmol) dissolved in dichloromethane 
(20 mL) were added 1,3-dimethoxybenzene (0.23 mL, 1.82 
mmol) and TFA (15.0 mL, 196.0 mmol) and the mixture was 
stirred for 6 h at room temperature. The solution was evapor-
ated in vacuo, and the residue was coevaporated with 
acetonitrile (5x). The residue was dissolved in methanol (1 
mL), diethyl ether (4.5 mL) was added, and the mixture was 
stored at 4 °C overnight. The resulting gum was triturated with 
diethyl ether, filtered and recrystallized from methanol (80 mL) 
to afford a white powder (0.59 g, 70%), mp 160.8-163.9 °C; R, 
0.76 (CH2Cl2-MeOH 6:4) (Found: C, 62.8; H, 4.65; N, 14.9. 
Calc. for C M H 3 I N A : C, 62.9; H, 4.8; N, 15.1%); ^ ( E t O H ) / 
nm 206 0g e 4.74), 266 (4.43), 278 (4.43), 289 (4.44), 299sh (4.35); 
v j e m " 1 3440m, 3222w, 3102w, 3069w, 2978w, 2946w, 1713m, 
1693w, 1647m, 1603m, 1582w, 1525m, 1500m, 1411w, 1252s, 
1178m, 762m; <5„ (500 MHz, rotamers) 3.15/3.59 (2 H, 2 m, 
CHJ , 3.18 (2 H, s, CHJ , 3.86 (3 H, s, CHjO), 4.03/4.10 (2 H, 2 
m, CHJ , 4.22 (1 H, m, CH), 4.30/4.39 (2 H, 2 m, CHJ , 5.20/ 
5.37 (2 H, 2 s, adenyl CHJ, 7.08 (2 H, d, 7 8.7, anisoyl CH), 
7.29/7.42 (1 H, 2 br t, NH), 7.32 (2 H, dd, 7 7.4 and 7.3, fluor-
enyl CH), 7.41 (2 H, dd, 77.4and 7.3,fluorenyl CH), 7.70 (2 H, 
d, 77.4, fluorenyl CH), 7.88 (2 H, d, 77.4, fluorenyl CH), 8.06 
(2 H, d, 7 8.7, anisoyl CH), 8.33 (1 H, s, H-8*), 8.62/8.67 (1 H, 2 
s, H-2*); mlz (ESI) 650 (100%, [M + H]+). 
{[2-(9/7-Fluoren-9-ylmethoxycarbonylamino)ethyl]-[2-(2-iso-
butyrylamino-6-oxo-l,6-dihydropurin-9-yl)acetyl]amino}acetic 
acid 25 
To ester 21 (0.68 g, 0.79 mmol) suspended in dichloromethane 
(20 mL), was added 1,3-dimethoxybenzene (0.125 mL, 0.95 
mmol) followed by TFA (7.34 mL, 95.3 mmol) and the mixture 
was stirred for 6 h at room temperature. The solution was evap-
orated in vacuo, and the residue was coevaporated with EtOAc 
(4x). The solid residue was triturated with EtOAc, and filtered 
(0.48 g, quant.), mp 202.0-206.0 °C and then recrystallized 
from ethanol (40 mL) to furnish a white powder (0.21 g, 45%), 
mp 208.8-210.6 °C (decomp.); from the mother liquor a further 
crop was obtained (0.026 g, 5%), mp 206.0-208.1 °C. Overall 
yield of the recrystallized product: 0.236 g, 50%. This reaction 
was repeated on a 3.0 mmol scale and afforded a quantitative 
yield of the crude arid 25 (1.80 g), mp 202.0-206.0 °C; R, 0.16 
(MeCN-MeOH-AcOH 8:1:1) (Found: C, 59.7; H, 5.3; 
N, 16.1. Calc. for C ^ N A : C, 59.9; H, 5.2; N, 16.3%); 
¿mu(EtOH)/nm 205 (lg e 4.79), 221sh (4.24), 256sh (4.45), 262 
(4.48), 278sh (4.29), 289sh (4.13), 300 (4.03); v ^ c m " 1 3350w, 
3131w, 3067w, 2965w, 2940w, 1693s, 1674m, 1610m, 1570m, 
1542m, 1485w, 1411m, 1250m, 1154w, 757w, 743w; <5„ (500 
MHz, rotamers) 1.11 [6 H, d, 7 6.6, (C//J2CH], 2.75 [1 H, 
pseudoquintet, 7 6.6, (CHJ2Ctf], 3.13 (1 H, m), 3.35 (1.8 H, 
m, partly shielded by the water signal) and 3.49 (1.2 H, m, 
2 x CHJ , 4.02/4.29 (2 H, 2 s, CHJ , 4.25 (1 H, m, CH), 4.32/4.38 
(2 H, 2 d, 75.8,6.5, CHJ , 4.97/5.13 (2 H, 2 s, guanyl CHJ , 7.261 
7.46 (1 H, 2 br t, NH*), 7.33 (2 H, m, fluorenyl CH), 7.41 (2 H, 
dd, 7 7.2 and 7.2, fluorenyl CH), 7.68 (2 H, dd, 7 7.5, 7.2, 
fluorenyl CH), 7.82 (1 H, s, H-8), 7.88 (2 H, d, 7 7.5, fluorenyl 
7. Chem. Soc., Perkin Trans. 1, 2000, 19-26 23 
CH), 11.59/11.65 (1 H, 2 s, NH*), 12.07 (1 H, s, NH)*, 12.50 
(1 H, br s, OH*); mlz (APCI) 602 (100%, [M + H]+). 
Acknowledgements 
This research has been supported by grants M KM 626, OTKA 
T 22551 and OTKA W 15521 (purchase of ChemProtect 1.0). 
References 
1 P. E. Nielsen, Annu. Rev. Biophys. Biomol Struct., 1995, 24,167. 
2 P. E. Nielsen and G. Haaima, Chem. Soc. Rev., 1997,26,73. 
3 B. Hyrup and P. E. Nielsen, Bloorg Med. Chem., 1996,4, 5. 
4 E. Uhlmann, A. Peyman, G. Breipohl and D. W. Will, Angew. 
Chem., Int. Ed., 1998,37, 2796. 
5 K. L. Dueholm, M. Egholm, C. Behrens, L. Christensen, H. F. 
Hansen, T. Vulpius, K. H. Petersen, R. H. Berg, P. E. Nielsen and 
O. Buchardt, J. Org. Chem., 1994,59, 5767. 
6 L. Christensen, R. Fitzpatrick, B. Gildea, K. H. Petersen, H. F. 
Hansen, T. Koch, M. Egholm, O. Buchardt, P. E. Nielsen, J. Coull 
and R. H. Berg, J. Pept. Set., 1995,1,175. 
7 D. W. Will, D. Langner, J. Knolle and E. Uhlmann, Tetrahedron, 
1995,51,12069. 
8 G. Breipohl, D. W. Will, A. Peyman and E. Uhlmann, Tetrahedron, 
1997,53,14671. 
9 S. A. Thomson, J. A. Josey, R. Cadilla, M. D. Gaul, C. F. Hassman, 
M. J. Luzzio, A. J. Pipe, K. L. Reed, D. J. Ricca, R. W Wiethe and 
S. A. Noble, Tetrahedron, 1995,51,6179. 
10 G. Breipohl, J. Knolle, D. Langner, G. Omalley and E. Uhlmann, 
Bioorg. Med Chem. Lett., 1996,6,665. 
11 L. A. Carpino, Acc. Chem. Res., 1987,20,401. 
12 P. Kocienski, Protecting Groups, Georg Thieme Verlag, Stuttgart, 
1994. 
13 E. Sonveaux, in Protocols for Oligonucleotide Conjugates, Methods 
tn Molecular Biology, ed. S. Agrawal, Humana Press, Totowa, 1994, 
vol. 26, pp. 1-71. 
14 Hanessian Laboratory, ChemProtect 1.0, Department of Chemistry, 
Université de Montréal, Montréal, 1995. 
15 L. Kovâcs, Z. Timâr and B. Penke, presented at the 13lh 
International Round Table. Nucleosides, Nucleotides and their 
Biological Applications, Montpellier, France, 1998, Poster 78. 
16 F. P. Clausen and J. Juhl-Christensen, Org. Prep. Proced Int., 1993, 
25, 375. 
17 T. Kamimura, M. Tsuchiya, K. Koura, M. Sekine and T. Hata, 
Tetrahedron Lett., 1983,24,2775. 
18 M. J. Robins, R. Zou, F. Hansske, D. Madej and D. L. J. Tyrrell, 
Nucleosides, Nucleotides, 1989,8,725. 
19 M. J. Robins, R. Zou, Z. Guo and S. F. Wnuk, J. Org Chem., 1996, 
61,9207. 
20 T. F. Jenny, K. C. Schneider and S. A. Benner, Nucleosides, 
Nucleotides, 1992,11,1257. 
21 H. Köster, K. Kulikowski, T. Liese, W. Heinkens and V. Kohli, 
Tetrahedron, 1981,37,363. 
22 R. Zou and M. J. Robins, Can. J. Chem., 1987,65,1436. 
23 H. R. Kricheldorf and J. Kaschig, Justus Lleblgs Ann. Chem., 1976, 
882 
24 D. L. Hughes, Org React., 1992,42,335. 
25 D. L. Hughes, Org. Prep. Proced Int., 1996,28,127. 
26 S. Trippett and D. M. Walker, J. Chem. Soc., 1961,2130. 
27 H. A. Brune, M. Falck, R. Hemmer, G. Schmidtberg and H. G. Alt, 
Chem. Ber., 1984,117,2791. 
28 M. von Itzstein and M. Mocerino, Synth. Commun., 1990,20,2049. 
29 Y. El-Kattan, G. Gosselin and J. L. Imbach, J. Chem. Soc., Perkin 
Trans. 1,1994,1289. 
30 T. W. Greene and P. G. M. Wuts, Protective Groups tn Organic 
Synthesis, John Wiley and Sons, New York, 2nd edn., 1991, p. 246. 
31 A. Albert, in Physical and Phystcochemlcal Aids in Characterization 
and in Determination of Structure, Synthetic Procedures in Nucleic 
Acid Chemistry, ed. W. W. Zorbach and R. S. Tipson, John Wiley 
and Sons, New York, 1973, vol. 2, pp. 47-123. 
32 P. K. Bridson, G. Richmond and F. Yeh, Synth. Commun., 1990,20, 
2459. 
33 L. Müller, J. Am. Chem. Soc, 1979,101,4481. 
34 A. Bax, R. H. Griffey and B. L. Hawkins, J. Magn. Reson., 1983,55, 
301. 
35 A. Bax and M. F. Summers, J. Am. Chem. Soc., 1986,108,2093. 
36 A. Bax and D. Marion, J. Magn. Reson., 1988,78, 186. 
37 J. Kjellberg and N.-G. Johansson, Tetrahedron, 1986,42,6541. 
38 J. Boryski, J. Chem. Soc., Perkin Trans. 2,1997,649. 
39 G. Lowe and T. Vilaivan, I Chem. Soc, Perkin Trans. 1,1997, 539. 
40 D. D. Perrin and W. L. F. Armarego, Purification of Laboratory 
Chemicals, Pergamon Press, Oxford, 3rd edn., 1988. 
Paper a907832k 
II. 

Alkyl 2-(Guanin-9-yl)acetates 71 
A REGIOSELECTIVE SYNTHESIS OF ALKYL 2- (GUANIN-9-YL)ACETATES 
AS P N A B U I L D I N G BLOCKS FROM 7 - ( 4 - N I T R O B E N Z Y L ) G U A N I N E 
DERIVATIVES 
Györgyi FERENC7", Péter FORGÓ", Zoltán KELE2" and Lajos KOVÁCS3"-* 
" Department of Medicinal Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary; 
e-mail:1 gyorgyi@ovrisc.mdche.u-szeged.hu, 2 kele@ovrisc.mdche.u-szeged.hu, 
3 kovacs@ovrisc.mdche. u-szeged.hu 
b Department of Organic Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary; 
e-mail: pforgo@chem.u-szeged.hu 
Received July 29, 2004 
Accepted October 8. 2004 
Guanine derivatives substituted at N1 with 4-R-benzyl groups (R = H, MeO, N02) have been 
evaluated in the regioselective A^-alkylation of guanine. Given the capricious removal of 
(substituted) benzyl groups from guanine derivatives and pent-4-enoylation of guaninium 
hydrochloride, an improved alternative approach has been elaborated consisting in the 
pent-4-enoylation and per-O-acetylation of guanosine (8), 4-nitrobenzylation at N7 followed 
by N-glycoside hydrolysis (10), A^-alkylation (12) and deprotection with sodium dithionite 
to afford the peptide nucleic acid building block tert-butyl [Alz-(pent-4-enoyl)guanin-9-yl]-
acetate (14) in 36% overall yield. This avoids N7 regioisomer formation, solubility problems 
and any chromatographic purification. A remarkable influence of the O- and/or JVz-acyl 
groups on the stability of Al-glycosidic bond and reactivity of 2-amino group was observed. 
The structure of a pyrimidine by-product 16 arising from the imidazole ring-opening of 
guaninium salt 4d in alkaline medium has been elucidated by 2D NMR. 
Keywords: Guanine; Regioselective alkylation; Guanosine; Nucleoside analogues; Nucleo-
sides; Purines; Peptide nucleic acids. 
The regioselective alkylation of guanine at A/9 is an important synthetic 
route to pharmaceutically important acyclic nucleoside analogues (e.g. 
acyclovir, ganciclovir, HPMPG) and monomeric building blocks of oligo-
nucleotide analogues (e.g. peptide nucleic acids, PNA); however these reac-
tions are rarely regiospecific, leading to mixtures of 9- and 7-alkylated prod-
ucts which can be very difficult to separate1. 
The regioselectivity and yield in the synthesis of 7- or 9-substituted 
guanosine analogues can be high in the alkylation of persilylated guanine 
derivatives e.g. OMN.JV-diphenylcarbamoyft-A/Msobutyrylguanine with 
P-O-activated alkylation reagents1-2 e.g. peracylated sugars3. 9-Alkoxyalkyl-
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ated products can be ob ta ined in high yields even if an AP/N7 isomeric mix-
ture is fo rmed whi le the N7 to A/9 r ea r rangement takes place u p o n heat-
ing 4 - 1 0 or even at room tempera tu re in DMF n . 
The regioselectivity of the alkylat ion wi th non |3 -0-ac t iva ted , small-sized 
alkyl hal ides (e.g. alkyl haloaceta tes in the synthesis of PNA monomers ) 
unde r basic cond i t ions (e.g. K2CC>3) is still inadequate . Cons t r a in ing gua 
n ine in to its lactim form e.g. in the case of 2 -amino-6-ch loropur ine 1 2 - 1 7 , 
2 -amino-6- (a ry l su l fanyl )pur ines 1 8 or (^ - (N.N-d ipheny lca rbamoyl ) deriva-
tives1 9 improves the A/9/A/7 isomer ratio, but it is no t suff ic ient r equ i r emen t 
since the h ighes t yield of A/9 isomer was a r o u n d 75% and ch roma tog raph i c 
pur i f i ca t ion could n o t be avo ided in every case, f u r t h e r m o r e 2 -amino-
6-ch lo ropur ine is m u t a g e n i c a n d expensive, 2-amino-6-(arylsul fanyl)pur 
ines require a s t rong acidic t r ea tmen t , t he A(,Af-diphenylcarbamoyl g roup 
can be labile2 0 , 2 1 a n d this imposes l imi ta t ions on its applicabil i ty. There is a 
th i rd a p p r o a c h , howeve r , a f f o r d i n g exclusively 9 a lky la ted der ivat ives . 
Izawa e t al. repor ted an A^-regioselective subs t i tu t ion s tar t ing f rom guano-
sine2 2 , 2 3 . In their a p p r o a c h guanos ine was protected on A/7 wi th a (substi-
tuted) benzyl group; t hen , af ter acid hydrolysis of Al glycosidic b o n d and 
SCHEME 1 
The reaction sequence followed by Izawa et al.22 ,23 Reagents and conditions: (i) R'X, (ii) HC1, 
(iii) R2X, (iv) R3X, (V) removal of R1. fi-D-Rf = P-D-ribofuranosyl, R1 = substituted benzyl, R2 = 
acyl, R3 = alkyl 
o 
HÖ ÖH 
P 
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acylation of the amino group, 7-substituted benzyl-A^-acylguanines were 
alkylated selectively at A/9, then deprotected at A/7 in a good overall yield 
(ca. 80%, Scheme 1). In this case the (substituted) benzyl is not only a pro-
tective group but it activates the purine ring in alkylation22,23. 
RESULTS AND DISCUSSION 
The problem of the regioselectivity of the alkylation of guanine derivatives 
was present in the reaction of ieri-butyl bromoacetate with AP-isobutyryl-
guanine and 06-(N,A/-diphenylcarbamoyl)-A/2-isobutyrylguanine as the first 
step in the synthesis of Fmoc/acyl-protected PNA monomers24. In our ini-
tial study the Izawa method has been adopted for the regioselective A/9-
alkylation of guanine. Thus, 7-benzylguanine hydrochloride25 (2a), avail-
able from guanosine (1) in a one-pot procedure, was acylated with iso-
butyric anhydride and the resulting compound 3a was allowed to react 
with ieri-butyl bromoacetate (Scheme 2). The guaninium salt 4a was sub-
jected to hydrogenolysis to remove the benzyl group giving rise to ester 5a. 
All the steps afforded crystalline compounds, there was no need for chro-
matographic purification and the overall yield of the four-step process, 
starting from guanosine, was 37%. However, the last step often proved to 
be capricious and irreproducible. The notorious behavior of benzylated 
purines under hydrogenolysis is well documented26 and alternative N-
debenzylation with the potassium ieri-butoxide-dimethyl sulfoxide-oxygen 
system is not compatible with the vulnerable, base-sensitive groups27,28. 
Consequently, we decided to abandon the benzyl group. 
The 4-methoxybenzyl (PMB) group is known to be cleaved from ethers or 
amines under oxidative conditions29 thus the above reaction was repeated 
(Scheme 2) employing this group with the only difference being the appli-
cation of methyl bromoacetate as alkylating agent (the corresponding 
ieri-butyl ester was not crystalline). The intermediates 2b-4b were again 
nice crystalline compounds and the transformations were uneventful until 
the last step. The removal of the PMB group from 4b under oxidative 
(cerium ammonium nitrate30, DDQ31 , potassium peroxodisulfate32), 
catalytic33 or transfer hydrogenolytic34 or acid (AlCl3-anisole35,36, CBr4-
methanol37) conditions has not been successful. The PMB group in the 
guaninium moiety of compound 4b proved to be very resistant to the 
above reagents. 
The reductive deprotection of 4-nitrobenzyl (PNB) group is a well-
established method, therefore we have embarked upon the synthesis and 
use of 7-(4-nitrobenzyl)guanines. The reaction sequence carried out with 
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benzyl and PMB groups has been repeated with 4-nitrobenzyl bromide and 
standard transformations led to guaninium salt 4c (Scheme 2). The removal 
of PNB group has been accomplished with Zn/AcOH or In/AcOH and ester 
5a has been obtained from guanosine in 38-40% overall yield; however, 
the last step required chromatographic purification and removal of zinc 
acetate and the yellow by-product was cumbersome. 
In our experience the removal of guanine isobutyryl group was not quan-
titative in the cleavage and deprotection of PNA oligomers38. Therefore a 
change in the protective group was needed. Pent 4-enoyl group seems to be 
a better choice since it can be removed, in addition to the conventional 
ammonia, with iodine as well39-41. 
o 
HOH2c _ n ^ n ^ n h , — - r — • 
y u y 2 70-97% 
HO 6 H 
c & r N NH2 71-02% 
R1 Y 
N NHIbu 
71-93% 
R1 R1 
2a Bn 3a Bn 
2b PMB 3b PMB 
2c PNB 3c PNB 
R1 U 
NH 
I 
N NHIbu 
° y J xe 
R2O 
R1 R2 xG 
4a Bn f-Bu Bre 
4b PMB Me Br s 
4c PNB t-Bu B r 0 
4d PNB i-Bu PFf 
44-60% 
via 4c 
• tó 
y 
R2O 
O 
NH 
X
N NHIbu 
R2 
5a f-Bu 
5b Me 
PMB = 4-methoxybenzyl 
PNB = 4-nitrobenzyl 
SCHEME 2 
Reagents and conditions: (i) 1. R'Br, DMSO; 2. HCI, then MeOH. (ii) lbu 20, Et3N, DMF, 
150 °C, 3 h. (iii) BrCH2COOR2, DMF, 60 °C, 24 h. (iv) Zn, aq. AcOH, r.t., 18 h 
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7-(4-Nitrobenzyl)guanine hydrochloride (2c) did not dissolve well during 
the pent-4-enoylation, hence another route was needed to protect the 
2 amino group. Considering the high price of pent-4-enoic anhydride, the 
reactivity of the amino group and the solubility of compounds the se-
quence A^-acylation, A/Tprotection, iV-glycoside hydrolysis, A^-alkylation 
seemed to be the only good choice. 
A/MPentq enoyl)guanosine (6) was obtained in a high yield by tempo-
rary protection of hydroxy groups with the electron-donating trimethylsilyl 
group40 42. The 7,9-bis(4-nitrobenzyl)guaninium salt 11, detected in the re-
action mixture by TLC/MS, was the product in subsequent reaction with 
4-nitrobenzyl bromide (Scheme 3), 7-(4-nitrobenzyl)-iV2 (pent-4-enoyl)gua-
nine (10) could not even be detected. The formation of 7,9-bis(aryl-
methyl)guanines under forced conditions (elevated temperatures and pro-
longed reaction times) has been reported43. 
Enhancing the stability of the N-glycosidic bond is imperative for the 
monoalkylation of guanosine derivatives by introduction of electron-
withdrawing, e.g. acetyl groups to the hydroxy groups of the saccharide 
moiety. Pent-4-enoylation of 2',3',5'-tri O acetylguanosine was a slow and 
low-yielding process even at higher temperature, therefore 2',3',5' tri-O-
NHRZ 
PNB 
8 Ac3-ß-D-Rf 
R2 
H 
Pnt 
Pnt 
/ V ^ N H Î® J A 
,N N NHPnt 
R1 Br° 
78% 
via 9 
R1 
7 ß-D-Rf 
9 Ac3-p-D-Rf 
PNB 
NHPnt 
10 
PNB 
i® il A 
PNB Br® 
N NHPnt 
11 
SCHEME 3 
Reagents and conditions: (i) 1. TMSCi, pyridine, r.t., 1 h; 2. pent-4-enoic anhydride, pyridine, 
r.t., 16 h; 3. water, 0 -5 °C, 5 min; 4. aq. NH3, r.t., 30 min. (ii) 1-10 equiv. 4-nitrobenzyl bro-
mide, DMF, r.t., up to 6 days, see the text, (iii) AczO, pyridine, DMF, r.t., 16 h. (i) + (iii) 71%. 
p-D-Rf = p D-ribofuranosyl, AC3 P-D Rf = 2',3',5' tri-O-acetyl P-D-ribofuranosyl 
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acetyl-NMpenM-enoyOguanosine (8) was synthesized by acetylation of 
A/MpenM-enoyhguanosine (6). The formation of guaninium salt 9 was 
slow but compound 11 formed only in a negligible amount. The reaction 
was complete after 2.5 days with an usual 4-equivalent excess of the re-
agent. The excess of 4-nitrobenzyl bromide was scavenged by pyridine in 
order to avoid the formation of the dialkylated product 11 during evapora 
tion of the solvent (DMF). 4-Nitrobenzylpyridinium bromide and com-
pound 10 was separated with extraction after thermolysis of the N-
glycoside taking place at 70 °C without acid treatment. 
The extent of the influence of the O and/or A^-acyl groups on the stabil-
ity of A/ glycosidic bond and the reactivity of A2 was notable in the above 
reactions. 7-(4-Nitrobenzyl)guanosinium ion was stable but it decomposed 
spontaneously in the absence of acid after acylation on A/2. Acetylation of 
hydroxy groups in compound 7 stabilized the Af-glycosidic bond at room 
temperature but thermolysis took place without acid at 70 °C. The acetyl 
groups in 2',3',5'-tri-0-acetylguanosine withdrew the electron density of 
the purine ring and, at the same time, from the 2-amino group to such an 
extent that the acylation was not complete even after a prolonged time at 
100 °C. On the other hand, trimethylsilyl group activated the 2-amino 
group and the acylation took place smoothly. 
Alkylation of compound 10 affording guaninium salt 12 (Scheme 4), with 
3 equivalents of terf butyl bromoacetate at 70 °C was complete overnight. 
f-BuO 
SCHEME 4 
Reagents and conditions: (i) 3 equiv. tert-butyl bromoacetate, DMF, 70 °C, 16 h; (ii) 4 equiv. 
Na2S204, aq. acetone, pH 7.0, r.t., 30 min; (iii) 70 °C, 16 h; (ii) + (iii) 76% 
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As mentioned earlier, the purification of ester 5a after PNB removal with 
Zn/acetic acid was too laborious, therefore other reducing agents have been 
studied. 
Sodium sulfide was successfully used for the deprotection of 4-nitro-
benzyl esters and carbamates44 and our initial studies were conducted with 
salt 4d. In the sodium sulfide treatment, a new substance 12 (Scheme 5) 
emerged, the polarity of which was similar to the expected product 5a. 
However, in its MS spectrum the molecular ion [M + H]+ was observed at 
m/z 489 instead of at the expected value m/z 336. Imidazole ring opening is 
known to occur in alkaline solution as C-8 is electrophilic in salts45 like 4d. 
The exact position of formyl group (iV1 or N5) has not been ascertained 
earlier46 or only unconvincingly proved47. Our 2D NMR measurements 
(HSQC, HMBC) have unequivocally demonstrated (Fig. 1) that the formyl 
group is located on N5 confirming that the ensuing ring scission takes place 
between C-8 and N-9 atoms of guaninium salt 4d. Compound 16 exists as a 
7:1 mixture of rotamers at room temperature in DMSO-d6 solution. 
Reduction of the nitro group in compound 12 was complete within 
30 min in the presence of 4 equivalents of sodium dithionite even at pH 4, 
not only at pH 8-9 where deprotection of 4 nitrobenzyloxycarbonyl group 
was achieved44. To enhance the rearrangement of 4-aminobenzyl group 
leading to the deprotection, the reaction mixture was heated at 70 °C in a 
phosphate buffer (pH 7) and acetone was employed to obtain a homoge 
nous solution (the intermediacy of 13 was verified by TLC/MS, Scheme 4). 
NHIbu 
Oí-Bu . . Oí-Bu 
PNBO PNBO 
Of-Bu Oí-Bu 
16 BZ 
SCHEME 5 
Imidazole ring-opening of guaninium salt 4d in alkaline solution 
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Based on the observation that electron-donating substituents on phenyl 
ring and/or on a carbon atom promote the rearrangement by stabilizing 
the positive charge on benzyl methylene group in the removal of 4-nitro-
benzyl carbamates48, it was not suprising that heating of the reaction mix-
ture was required for the deprotection as, in our case, a positively charged 
substituent was attached to the benzyl methylene group decreasing the sta-
bility of the formed cation. 
Iminoquinomethane 15 was the elusive by-product of this deprotection 
regime. This compound has never been isolated in pure form due to its 
instability and tendency to polymerize48 50. We have been able to detect 
^ i I O 
- « Ä g 
I * T 
+ 
_1. 
NH 
ArCH2 CH2CO * * 
Ï++ I 
* 
At 
ArCH, — * 
2 + 
(CH 3)3C 
C-5 
C-3', C-5' 
C-2', C-6' 
H CO 
Î- - <J 
. + + 
8 (ppm) 8 
60 
80 
100 
- 120 
- 140 
160 
5 
4 (PPm) 
FIG. 1 
HMBC spectrum (detail) of compound 16. Crucial correlations are highlighted by boxes, 
primed numbers denote atoms in the benzene ring. Some signals are doubled in the major (*) 
and minor (+) rotamers, e.g. the formyl protons at 7.99 (*) and 8.38 ppm (+), respectively 
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in the ESI mass spectrum peaks of this substance at m/z 106 and m/z 138 
corresponding to ions [M + H]+ and [M + MeOH + H]+, respectively, but our 
further attempts to characterize this compound have not been rewarding. 
The presence of this substance as a contaminant was obvious in both the 
yellow-colored aqueous and the organic phases. It was attempted to scav-
enge the substance with sulfites49 (oxidized form of dithionite), however, 
it was impossible to completely remove this substance from the product. 
The slightly yellowish amorphous product 14 was easily obtained by wash-
ing with ethyl acetate; it was completely pure according to TLC and NMR 
analyses. 
The site of the alkylation (A/9 vs N7) in guanine derivatives can be unequi-
vocally ascertained by iH 18-5152, i3c24.5i.52 a n d isN NMR53 or MS/MS54 
methods. In this study our 13C NMR method24 was used. The structures of 
CH2COO 
P h C H, 
H-8 arom. CH 
I 
C-5 -i 
arom. 
CH 
arom. 
Cq 
C - 8 -
C-4 -
COO-
8 (ppm) 10 
0 110 
120 
130 
226 Hz 
t t 0 « 0 
0 150 
160 
8 
. 8 
(ppm) 
FIG. 2 
HMBC spectrum (detail) of compound 4a. Crucial correlations are highlighted by boxes 
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compounds 3, 10 and 14 were corroborated by the chemical shift difference 
parameters a = Sc.4 - 8C.5> b = Sc.8 - Sc.5 and c = §c.5 - Sc.!-, involving C 1', 
C-4, C-5 and C-8 which are the most sensitive to the site of alkylation (data 
not shown). It is noteworthy that the guaninium salts display an unusually 
large heteronuclear coupling constant between H 8 and C-8 (e.g. VH S.C-S = 
226 (4a) and 227 Hz (4c)), which indicates the imidazolium substruc-
ture55-57. The structure of compound 4a has been corroborated by HSQC 
and HMBC investigations as well (Fig. 2). 
In our study directed to 9-substituted guanines, the application of gua-
nine derivatives substituted at A/7 with different benzyl groups (benzyl, 
4-methoxybenzyl, 4 nitrobenzyl) has been evaluated. The general sequence 
exemplified in Schemes 1 and 2 proved to be problematic in terms of easy 
and reproducible removal of protecting group at N7 and acylation of com 
pounds 2 with pent-4-enoic anhydride. Our improved alternative approach 
described in this paper comprises the following steps: (i) pent-4-enoylation 
of guanosine at N2 (6), (ii) per-0 acetylation (8), (iii) 4-nitrobenzylation at 
IV7 (9), (iv) hydrolysis of the N-glycoside 9 (10), (v) AP-alkylation (12) and 
(vi) deprotection with sodium dithionite. This seemingly lengthy procedure 
can be combined into four distinct, well-reproducible steps with standard 
transformations affording the PNA building block ferf-butyl [A/2 (pent-
tó1 N 
R'1 
I, 
71% c 
II 
78% 
R1 
ß-D-Rf 
8 ACß-ß-D-Rf 
R2 
H 
Pnt 
PNB 
tó 
10 
NHPnt 
m 
86% 
PNB 
NH 
O 
V J JL °yJ 
f-BuO 
12 
NHPnt 
Bre 
76% A N ^ N NHPnt V 
f-BuO 
14 
SCHEME 6 
Reagents and conditions: (i) 1. TMSC1, pyridine, r.t., 1 h; 2. 1.25 equiv. pent-4-enoic an-
hydride, pyridine, r.t., 16 h; 3. water, 0 -5 °C, 5 min; 4. aq. NH3, r.t., 30 min; 5. Ac20, pyridine, 
DMF, r.t., 16 h. (ii) 4 equiv. 4-nitrobenzyl bromide, DMF, r.t., 60 h. (iii) 3 equiv. rert-butyl 
bromoacetate, DMF, 70 °C, 16 h. (iv) 1. 4 equiv. Na2S204 , aq. acetone, pH 7.0, r.t., 30 min; 2. 
70 °C, 16 h. p-D-Rf = P-D-ribofuranosyl, Ac3-P-D-Rf = 2',3',5'-tri-0-acetyl-P-D-ribofuranosyl 
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4-enoyl)guanin-9-yl]acetate (14) with no A/7 regioisomer formation, solubil-
ity problems or chromatographic purification (Scheme 6) with the same 
36% overall yield as in the case of Izawa et al. method. Main advantages of 
our synthesis are the acylation of A/2 amino group at room temperature due 
to the high solubility of the starting compound and a reproducible removal 
of the 4-nitrobenzyl group. Attempts at the conversion of 14 to a guanine 
PNA monomer are under way. The extent of the influence of the O- and/or 
A^-acyl groups on the stability of N-glycosidic bond and reactivity of 
2-amino group is remarkable. The site of the alkylation in 7- and 9-alkyl-
ated guanine derivatives has been corroborated by chemical shift differ-
ences of 13C NMR spectra. Position of the formyl group (A/5) in the ring-
opened derivative 16 formed from guaninium salt 4d under alkaline condi-
tions (Scheme 5) has been unravelled by 2D NMR. 
EXPERIMENTAL 
The following abbreviations are employed: Bn (benzyl), f-Bu (terf-butyl), TMSC1 (chloro-
trimethylsilane), DDQ (2,3-dichloro-5,6-dicyano-l,4-benzoquinone), EtzO (diethyl ether), 
DMF (N,N-dimethylformamide), DMSO (dimethyl sulfoxide), ESI (electrospray ionization), 
EtOAc (ethyl acetate), Fmoc (fluoren-9-ylmethoxycarbonyl), Ibu (isobutyryl), MeOH (metha-
nol), PMB (4-methoxybenzyl), PNB (4-nitrobenzyl), Pnt (pent-4-enoyl), PNA (peptide nucleic 
acid(s)), r.t. (room temperature), TEA (triethylamine). 
Chemicals were purchased from Aldrich, Fluka, Merck or Reanal (Budapest, Hungary). 
Pent-4-enoic anhydride was alternatively synthesized from pent-4-enoic acid as described in 
literature58,59. Compound 2a was prepared as described25. Compounds 2b and 2c were pre-
pared in an analogous way60. 4-Methoxybenzyl bromide is prone to decomposition and it 
was freshly prepared prior to use from the corresponding alcohol61. Anhydrous solvents 
were prepared as described62. Organic solutions were dried using anhydrous MgS04 and 
evaporated in Biichi rotary evaporators. TLC: Kieselgel 60 F2S4 (Merck); solvent systems: 
CH2Cl2-MeOH 9:1 (SI), CH2Cl2-MeOH 95:5 (S2), CH2Cl2-iPrOH 5:0.25 (S3); visualization: 
UV light, H2S04/ethanol. All guaninium salts gave oval spots with significant tailing. M.p.: 
Electrothermal IA 8103 apparatus. Elemental analysis: Perkin-Elmer CHN analyzer model 2400. 
UV: PE Lambda 10 spectrometer, Xmax in nm (log e); sh, shoulder. Stock solutions were made 
in ethanol except of compounds 3b and 10, in which cases adding DMSO was necessary to 
achieve clear solutions. In the case of latter samples and TEAc buffer the region below 
220 nm in UV spectra was uncertain, because these compounds have high absorbance in 
this region. NMR: Bruker Avance DRX 500 spectrometer ('H: 500.13 MHz, >3C: 125.76 MHz), 
DMSO-d6 solutions; 5 (ppm), J (Hz). Spectral patterns: s, singlet; d, doublet; dd, double dou-
blet; t, triplet; m, multiplet; br, broad; deut, deuterable. The superscripts *, # denote inter-
changeable assignments. For the 2D experiments (HMQC, HMBC), standard Bruker software 
packages (INV4GSSW, INV4GSLRNDSW) were used. Mass spectrometry: Finnigan MAT TSQ 
7000, electrospray (ESI) technique. TLC/MS: the analyte solution has been applied onto a 
5 cm wide silica gel TLC plate as a band to obtain sufficient material. After developing in a 
solvent system, the appropriate band was scraped off with a spatula, the silica gel was 
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suspended in MeOH (100 pi), sonicated, centrifuged and the supernatant was used for MS 
analysis. 
7-Benzyl-A/2-isobutyrylguanine (3a) 
Compound25 2a (8.393 g, 30.2 mmol) suspended in anhydrous DMF (90 ml) was treated 
with isobutyric anhydride (12.50 ml, 75.5 mmol) and TEA (8.43 ml, 60.4 mmol) and the 
mixture was heated with stirring at 150 °C for 3 h. The homogeneous solution was evapo-
rated in vacuo, coevaporated with MeOH (2x), triturated under cold water, filtered and 
dried. The crude product (8.913 g) was boiled with ethanol (200 ml), the obtained solution 
filtered and the filtrate was evaporated to dryness. Trituration under cold ether gave the title 
compound (6.663 g. 70.8%) as beige ciystals, m.p. 176-178 °C. RP0.65 (SI). For C 1 6 H l 7 N s 0 2 
(311.3) calculated: 61.7% C, 5.5% H, 22.5% N; found: 61.55% C. 5.4% H. 22.7% N. UV: Xmax 
(50% (v/v) 1 M HC1 in EtOH, pH 0) 202 sh (4.22), 267 (3.98); km a x (50% (v/v) 1 M TEAc in 
EtOH, pH 7) 267 (3.97): (50% (v/v) 0.1 M KOH in EtOH, pH 13) 272 (3.82). 'H NMR: 
1.12 d, 6 H, / = 6.8 ((CH3)2CH); 2.75 pseudo t, 1 H, / = 6.8 ((CH3)2CH); 5.52 s, 2 H (CH2); 
7.29-7.34 m, 5 H (C6H5); 8.33 s. 1 H (H-8); 11.49 s, 1 H (NH); 12.13 s, 1 H (NH). 13C NMR 
(/-modulated spin-echo): 18.65 ((CH3)2CH); 34.52 ((CH3)2CH); 49.08 (PhCHJ; 110.99 (C-5); 
127.32, 127.64, 128.45 (arom. CHs); 137.09 (arom. Cq); 144.08 (C-8); 147.00, 152.49, 157.07 
(C-2, C-4, C-6); 179.75 (iPrCO). MS (ESI), m/z (rel.%): 623 (30) [2 M + H f ) . 312 (100) (M + H]*. 
A^-Isobutyryl-7- (4-methoxybenzyl)guanine (3b) 
Prepared from 7-(4-methoxybenzyl)guanine hydrochloride60 (2b; 7.8 mmol scale) as de-
scribed for compound 3a (1.989 g, 74.7%). An analytical sample was obtained by recrystal-
lizing the product from acetonitrile (4.6 g/100 ml), m.p. 185.9-186.6 "C (acetonitrile). 
RF 0.48 (SI). For C 1 7 H 1 9 N 5 0 3 (341.4) calculated: 59.8% C, 5.6% H, 20.5% N; found: 
59.6% C, 5.65% H, 20.3% N. UV: Xmax (50% (v/v) 1 M HCI in EtOH. pH 0) 223 (4.13), 267 
(4.08); XMSX (50% (v/v) 1 M TEAc in EtOH, pH 7) 267 (4.00); XM3X (50% (v/v) 0.1 M KOH in 
EtOH. pH 13) 271 (3.90). 'H NMR: 1.10 d, 6 H, J = 6.8 ((CH3)2CH); 2.74 pseudo t, 1 H. / = 
6.8 ((CH3)2CH); 3.71 s, 3 H (CH30); 5.42 s, 2 H (CH2); 6.88 d. 2 H, / = 8.5 (ArH); 7.33 d. 2 H. 
J = 8.5 (ArH); 8.31 s. 1 H (H-8); 11.51 s, 1 H (NH); 12.13 s, 1 H (NH). 13C NMR (/-modulated 
spin-echo): 18.75 ((CH3)2CH); 34.60 ((CH3)2CH); 48.66 (ArCH2); 54.98 (CH30); 110.92 (C-5); 
113.92 (C-3', C-5'); 129.12, 129.17 (C-2', C-6', C-l*); 143.97 (C-8); 147.02, 152.57, 157.18, 
158.86 (C-2, C-4, C-6, C-40; 179.84 (iPrCO). MS (ESI), m/z (rel.%): 683 (32) [2 M + H]*, 342 
(100) [M + H] \ 
/V2-Isobutyryl-7-(4-nitrobenzyl)guanine (3c) 
Prepared from 7-(4-nitrobenzyl)guanine hydrochloride60 (2c; 8.6 mmol scale) as described 
for compound 3a (2.512 g, 81.8%). The substance was sufficiently pure for further transfor-
mations, however, it can be reciystallized from MeOH (2.0 g/150 ml), m.p. > 260 °C. RP 0.68 
(SI). For C I 6H,6N604 (356.3) calculated: 53.9% C. 4.5% H. 23.6% N; found: 53.75% C, 4.6% H, 
23.4% N. UV: Xmax (50% (v/v) 1 M HCI in EtOH. pH 0) 201 (4.22), 218 (4.05), 267 (4.11); 
XM3X (50% (v/v) 1 M TEAc in EtOH, pH 7) 267 (4.15); Xmax (50% (v/v) 0.1 M KOH in EtOH, 
pH 13) 272 (4.11). 'H NMR: 1.10 d, 6 H. / = 6.7 ((CHJ2CH); 2.72 pseudo t, 1 H. / = 6.7 
((CH3)2CH); 5.66 s. 2 H (CH2); 7.53 d , 2 H , / = 8.3 (ArH); 8.18 d. 2 H, / = 8.3 (ArH); 8.38 s, 
1 H (H-8); 11.55 s, 1 H (NH); 12.13 s, 1 H (NH). 13C NMR (/-modulated spin-echo): 18.77 
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((CH3)2CH); 34.64 ((CH3)2CH); 48.61 (ArCH2); 111.06 (C-5); 123.72, 128.43 (arom. CHs); 
144.51 (C-8); 144.64, 146.97, 147.29, 152.51, 157.36 (C-2, C-4, C-6, C-l ' , C-4'); 179.92 
(iPrCO). MS (ESI), m/z (rel.%): 713 (5) (2 M + H] \ 357 (100) [M + H) \ 
7-Benzyl-9-[(tert-butoxycarbonyl)methyl)-/V2-isobutyrylguaniniurn Bromide (4a) 
Compound 3a (1.557 g, 5.0 mmol) dissolved in warm DMF (20 ml) was allowed to react 
with tert-butyl bromoacetate (0.813 ml, 5.5 mmol) at 60 °C for 24 h. The solution was evap-
orated in vacuo, coevaporated with EtOAc (3x) and EtOAc was added (20 ml). The resulting 
oil slowly ciystallized in a refrigerator (1.801 g. 71%), m.p. 158 °C (dec., EtOAc). RF ca. 0.2 
(SI). For C22H28BrN504 (506.4) calculated: 52.2% C. 5.6% H. 13.8% N; found: 52.0% C. 
5.7% H, 13.65% N. UV: \ m a x (50% (v/v) 1 M HC1 in EtOH, pH 0) 201 (4.26), 271 (3.97): X m „ 
(50% (v/v) 1 M TEAc in EtOH. pH 7) 278 (3.70); Xmax (50% (v/v) 0.1 M KOH in EtOH, pH 13) 
243 (3.96). 'H NMR: 1.12 d, 6 H, / = 6.9 ((CH3)2CH); 1.44 s. 9 H (t-Bu); 4.02 pseudo t, 1 H, 
J = 6.9 ((CH3)2CH); 5.19 s, 2 H (CH2COO); 5.82 s. 2 H (PhCH2); 7.39-7.50 m, 5 H (C6H5); 
9.87 s, 1 H (H-8); 12.10 br s. 1 H (NH); 12.70 s. 1 H (NH). 13C NMR (/-modulated spin-echo, 
HSQC, HMBC experiments): 18.56 ((CH3)2CH); 27.48 ((CH3)3C); 34.72 ((CH3)2CH); 46.40 
(CH2COO); 51.65 (PhCH2); 83.57 ((CH3)3C); 109.61 (C-5); 128.16, 128.80 (arom. CHs); 
134.04 (arom. Cq); 140.28 (C-8); 147.55 (C-4); 151.13 (C-2. C-6); 164.62 (COO); 180.52 
(iPrCO). MS (ESI), m/z (rel.%): 426 (100) M*. guaninium ion. 
Nz-Isobutyryl-7-(4-methoxybenzyl)-9-[(methoxycarbonyl)methyl]guaninium Bromide (4b) 
Prepared from compound 3b (5.33 mmol) as described for compound 4a (2.382 g, 90%), 
m.p. 147.3-150.6 "C (EtOAc). RF ca. 0.2 (SI). For C20H24BrN5O5 (494.3) calculated: 48.6% C. 
4.9% H, 14.2% N; found: 48.55% C, 5.0% H. 14.35% N. UV: Xmax (50% (v/v) 1 M HC1 in 
EtOH. pH 0) 200 sh (4.45), 270 (4.02); Xm3x (50% (v/v) 1 M T E A C in EtOH. pH 7) 273 (3.83); 
A.max (50% (v/v) 0.1 M KOH in EtOH. pH 13) 273 (3.80). 'H NMR: 1.11 d. 6 H. / = 6.7 
((CH3)2CH); 2.80 pseudoquintet, l H , / = 6.7 ((CH3)2CH); 3.74 and 3.76 each s, 6 H 2 x 
(CH30); 5.30 s. 2 H (CH2COO); 5.72 s, 2 H (ArCH2); 6.97 d. 2 H, / = 8.3 (ArH); 7.49 d. 2 H. 
J = 8.3 (ArH); 9.77 s, 1 H (H-8); 12.05 br s, 1 H (NH); 12.60 s. 1 H (NH). 13C NMR (/-modu-
lated spin-echo): 18.50 ((CH3)2CH); 34.70 ((CH3)2CH); 45.89 (CH2COO); 51.36 (ArCH2); 
52.98, 55.13 (2 x CH30); 109.63 (C-5); 114.21, 130.19 (arom. CHs); 125.56 (C-l'*); 141.03 
(C-8); 147.60 (C-4'*); 151.04, 151.10, 159.64 (C-2. C-4. C-6); 166.23 (COO); 180.49 (iPiCO). 
MS (ESI), m/z (rel.%): 414 (100) M*. guaninium ion. 
9-((teri-Butoxycarbonyl)methyl]-N2-isobutyryl-7-(4-nitrobenzyl)guaninium Bromide (4c) 
and Hexafluorophosphate (4d) 
Prepared from compound 3c (10.0 mmol) as described for compound 4a. The bromide ciys-
tallized very sluggishly. It was very well soluble in EtOAc, therefore a water-insoluble 
hexafluorophosphate salt (4d) was prepared as follows. The crude oily product from the 
above reaction was dissolved in acetonitrile (20 ml) and ammonium hexafluorophosphate 
(1.793 g, 11.0 mmol) in water (10 ml) was added. The solution was evaporated, the residue 
was triturated under cold water and the precipitate was stored in vacuo over P 2 0 5 (5.732 g, 
93.0%). The title hexafluorophosphate dissolves well in cold MeOH, EtOAc, CH2C12 and 
acetonitrile but not in Et20 or water. The salt can be precipitated from acetonitrile solution 
by adding water. M.p. 126.8-127.5 °C (aqueous acetonitrile). RP (4c) ca. 0.10 (SI). For 
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C2 2HZ 7F6N606P (4d; 616.4) calculated: 42.9% C, 4.4% H, 13.6% N; found: 42.65% C, 
4.35% H, 13.4% N. UV (4c): \ m a x (50% (v/v) 1 M HC1 in EtOH, pH 0) 200 sh (4.50), 270 
(4.31); XM3X (50% (v/v) 1 M TEAc in EtOH, pH 7) 271 (4.08); Xmax (50% (v/v) 0.1 M KOH in 
EtOH. pH 13) 245 (4.11), 269 (4.06). 'H NMR (4C): 1.10 d. 6 H, / = 6.7 ((CH3)2CH); 1.45 s, 
9 H (t-Bu); 2.81 pseudoquintet, 1 H, / = 6.7 ((CH3)2CH); 5.22 s, 2 H (CH2COO); 5.99 s, 2 H 
(ArCH2); 7.73 d. 2 H. / = 8.3 (ArH); 8.24 d, 2 H. J = 8.3 (ArH); 9.95 s, 1 H (H-8); 12.10 br s, 
deut, 1 H (NH); 12.50 br s, deut, 1 H (NH). 13C NMR (4c; /-modulated spin-echo): 18.61 
((CH3)2CH); 27.55 ((CH3)3C); 34.77 ((CH3)2CH); 46.54 (CHzCOO); 50.99 (ArCHz); 83.68 
((CH3)3C); 109.72 (C-5); 123.76, 129.29 (arom. CHs); 141.42, 147.52, 147.68, 151.04, 151.21 
(C-1'. C-4', C-2, C-4, C-6, C-8); 164.64 (COO); 180.58 (iPrCO). MS (ESI) (4c), m/z (rel.%): 471 
(100) M*, guaninium ion. 941 (10) [2 M - H T -
tert-Butyl (A^-Isobutyiylguanin-9-yl)acetate24 (5a) 
Compound 4c (0.240 g, 0.435 mmol) was dissolved in 50% (v/v) acetic acid (5 ml), zinc 
powder (0.178 g, 2.72 mmol, 6.0 equivalents) was added and the mixture was stirred at 
room temperature for 18 h. A further portion of zinc powder (0.090 g) was added and stir-
ring was continued for 6 h. The zinc almost completely dissolved and a yellow precipitate 
was formed. After filtration through a Hyflo bed and thorough washing with acetonitrile, 
the solution was evaporated and dissolved in a mixture of dichloromethane (25 ml) and 
water (25 ml). The aqueous phase was extracted with dichloromethane (25 ml) and the com-
bined organic phases were washed with 0.05 M EDTA disodium salt (2 x 10 ml), dried and 
evaporated in vacuo (0.077 g). The Hyflo bed was washed again with acetonitrile and a com-
bined crop of 0.130 g was obtained. Chromatography (CH2Cl2-MeOH 98:2 to 94:6) yielded 
0.064 g (43.8%), m.p. 203 °C. RP 0.13 (S2). The NMR and MS data of the product were in 
full agreement with those previously published24. In another experiment after the work-up 
as above, the resulting red oil was coevaporated with acetonitrile (3x) and the yellow solid 
obtained (0.82 g, 60%) showed a single spot on TLC. Further trituration under ether yielded 
a purer product (0.60 g, 44%). 
2',3',5'-Tri-0-acetyl-Afz-(pent-4-enoyl)guanosine (8) 
Guanosine hydrate (8.8 g, 31.1 mmol) was suspended in acetonitrile (2 x 100 ml) and evap-
orated to dryness. Chlorotrimethylsilane (30 ml, 234 mmol) was added dropwise (20 min) to 
the suspension of dried guanosine in anhydrous pyridine (150 ml) and stirred for another 
40 min. Pent-4-enoic anhydride (7.10 ml, 38.9 mmol, 1.25 equivalents) was added and the 
reaction was stirred at room temperature for 16 h. The cooled reaction mixture was diluted 
with water (30 ml) and treated with ammonia solution (30 ml, 25%) for 30 min. The residue 
was dissolved in water (400 ml) and extracted with a mixture of Et20 and EtOAc (1:1 v/v, 
400 ml). The water phase was evaporated, then coevaporated with acetonitrile (2 x 300 ml) 
and used for the next step without further purification. 
Alz-(Pent-4-enoyl)guanosine (6) was dissolved in a mixture of DMF (44 ml) and pyridine 
(22 ml). Acetic anhydride (18 ml) was added to the mixture, the pyridinium salts from the 
previous step were filtered off and the solution was set aside for 16 h. Ethanol (10 ml) was 
added to the solution, then the residue was dissolved in EtOAc (400 ml) and extracted with 
1 M hydrochloric acid (2 x 300 ml) and saturated NaHC03 solution (2 x 300 ml). Evapora-
tion in vacuo after drying gave the product as a white solid foam (10.9 g, 71%). R f0.30 (S2), 
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0.45 (S3). UV: XMAX (50% (v/v) 1 M HC1 in EtOH, pH 0) 202 (4.20), 260 (3.97), 281 (3.84); 
(50% (v/v) 1 M TEAc in EtOH, pH 7) 260 (4.00), 281 (3.87); Xmax (50% (v/v) 0.1 M KOH 
in EtOH, pH 13) 266 (3.97). 'H NMR: 2.03 s, 3 H (CH3CO); 2.04 s, 3 H (CH3CO); 2.11 s. 3 H 
(CH3CO); 2.34 m. 2 H (CH2CH=CH2); 2.58 t, 2 H. / = 7.2 (CH2CO); 4.29 m, 1 H (H-4J; 
4.37 m, 2 H (H-5'); 4.99 d, 1 H, / = 10.2 (c/s-CH2=CH); 5.06 d. 1 H. / = 17.2 (fra/is-CH2=CH); 
5.48 dd. 1 H J = 5.7. / = 3.7 (H-3'); 5.81 m. 2 H (H-l', CH2=CH); 6.08 d. 1 H. / = 6.3 (H-20; 
8.23 s, 1 H (H-8); 11.60 br s, 1 H (NH); 12.06 br s, 1 H (NH). 13C NMR (decoupled and 
/-modulated spin-echo spectra): 20.03, 20.25, 20.39 (3 x CH3CO); 28.07 (CH2CH=CH2); 
35.10 (CH2CO); 63.00 (C-5'); 70.28 (C-3'*); 72.16 (C-2'*); 79.83 (C-4'*); 84.56 (C-l'); 115.54 
(CH2=CH); 120.37 (C-5); 136.73 (CH2=CH); 137.74 (C-8); 148.06 (C-2*): 148.57 (C-6#); 
154.65 (C-4); 169.15, 169.35, 169.99 (3 x CH3CO); 175.46 (C„H7CONH). MS (ESI), m/z 
(rel.%): 492.16 (100) [M + H] \ 
7- (4-Nitrobenzy 1)- if- (pent-4-enoyl)guanine (10) 
Compound 8 (4.9 g, 10.0 mmol) dissolved in anhydrous DMF (60 ml) and 4-nitrobenzyl 
bromide (8.6 g, 40.0 mmol) were stirred at room temperature for 60 h. When the reaction 
was complete, pyridine (6.4 ml, 80 mmol) was added to scavenge excess of the alkylation re-
agent and set aside for 5 h. The reaction mixture was heated at 70 °C for 16 h to thermolyse 
the guaninium salt 9. The solution was evaporated in vacuo and EtOAc (400 ml) and water 
(400 ml) were added to the oily residue. The product (2.3 g, 62%) was precipitated and fil-
tered off. A further crop (0.6 g, 16%) was precipitated when the residue from the evaporated 
organic phase was treated with CH2C12 (10 ml). Overall yield of 10: 2.9 g (78%), amorphous 
so l id . RF 0 . 2 9 (S2). 0 . 2 2 (S3). UV: XM3X (50% (v/v) 1 M HC1 in EtOH, p H 0) 267 (4.15); XMAX 
(50% (v/v) 1 M TEAc in EtOH, pH 7) 267 (4.14); XMAX (50% (v/v) 0.1 M KOH in EtOH, pH 13) 
272 (4.11). 'H NMR: 2.32 m, 2 H (CH2CH=CH2); 2.53 t. 2 H, / = 7.2 (CH2CO); 4.97 d, 1 H, / = 
10.2 (c/s-CH2=CH); 5.04 d, 1 H. / = 17.1 (&ans-CH2=CH); 5.65 s, 2 H (ArCH2); 5.77-5.85 m, 
1 H (CH2=CHCH2); 7.52 d. 2 H, / = 8.5 (ArH); 8.17 d, 2 H, / = 8.5 (ArH); 8.37 s, 1 H (H-8); 
11.57 br s. 1 H (NH); 12.08 br s, 1 H (NH). 13C NMR (decoupled and/-modulated spin-echo 
spectra): 28.13 (CH2=CHCH2); 34.96 (CH2CO); 48.60 (ArCH2); 111.08 (C-5); 115.49 
(CH2=CH); 123.68, 128.44 (arom. CH); 136.73 (CH2=CH); 144.49, 144.54, 147.00, 152.47, 
157.33 (C-8, C-l', C-4', C-2, C-6, C-4); 175.26 (C4H7CONH). MS (ESI), m/z (rel.%): 368.97 
(100) [M + HP. 
tert-Butyl ({2-Isobutyramido)-5-[A/-(4-nitrobenzyl)formamido)-
6-oxo-l,6-dihydropyrimidin-4-yl)amino)acetate (16) 
To compound 4d (0.308 g, 0.5 mmol) dissolved in acetone (3 ml) was added sodium sulfide 
nonahydrate (0.48 g, 2.0 mmol) in water (1 ml) and the mixture was stirred at room tem-
perature for 2 h. The reaction mixture was diluted with water (20 ml) and extracted with 
CH2C12 (3 x 10 ml), the organic layer was dried and evaporated (0.178 g, 73%), m.p. 191 °C 
(dec.). RP 0.39 (S2). For C2 2H2 8N607 (488.5) calculated: 54.1% C, 5.8% H, 17.2% N; found: 
53.9% C. 5.95% H, 16.95% N. UV: XMAX (50% (v/v) 1 M HC1 in EtOH, pH 0) 201 (4.24), 232 
(4.42), 276 (4.00); A.max (50% (v/v) 1 M TEAc in EtOH, pH 7) 276 (3.94); XMIX (50% (v/v) 
0.1 M KOH in EtOH, pH 13) 245 (4.09), 270 (4.02). 'H NMR (HSQC, HMBC, see Fig. 1. major 
rotamer): 1.06 d, 6 H. / = 6.5 ((CH3)2CH); 1.37 s, 9 H (t-Bu); 2.73 pseudoquintet, 1 H, / = 6.5 
((CHjJjCH); 3.96 m, 2 H (CH2COO); 4.41, 4.97 2 x d. 2 x 1 H, / = 15.2 (ArCHj); 7.29 t, 1 H, 
/ = 6.0 (NH); 7.64 d, 2 H. / = 8.5 (ArH); 7.99 s. 1 H (HCO); 8.08 d. 2 H. / = 8.5 (ArH); 
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11.30 br s, 1 H (NH); 11.41 br s. 1 H (NH). 13C NMR (HSQC, HMBC, see Fig. 1. major rota-
mer): 18.62 ((CH3)2CH); 27.65 ((CH3)3C); 34.58 ((CH3)2CH); 42.90 (CH2COO); 46.82 
(ArCHJ; 80.74 ((CH3)3C); 96.83 (C-5): 122.95 (C-3'. C-5'); 129.74 (C-2', C-6'); 144.90 (C-1*); 
146.60 (C-4"); 149.36 (C-2*); 158.15 (C-6*); 159.42 (C-4); 165.14 (HCO); 169.20 (COOr-Bu); 
180.36 (iPrCO). MS (ESI), m/z (rel.%): 977.6 (48) [2 M + H]+, 489 (100) [M + H] \ 
9-[(teit-Butoxycarbonyl)methyl-7-(4-nitrobenzyI)-A^-(pent-4-enoyI)guaninium Bromide (12) 
tert-Butyl bromoacetate (1.2 ml, 8.1 mmol) was added to a solution of compound 10 (1.0 g, 
2.7 mmol) in anhydrous DMF (40 ml) and heated at 70 °C for 16 h. The residue obtained af-
ter evaporation was dissolved in a phosphate buffer (60 ml, pH 7.0) and extracted with EtzO 
(60 ml). The title salt 12 (1.30 g, 86%) precipitated as a white amorphous solid. Rf 0.21 (SI). 
UV: Xmax (50% (v/v) 1 M HC1 in EtOH, pH 0) 201 sh (4.28), 270 (4.14); Xm3x (50% (v/v) 1 M 
TEAc in EtOH. pH 7) 272 (4.02); X m (50% (v/v) 0.1 M KOH in EtOH. pH 13) 245 (4.02), 269 
(3.98). 'H NMR: 1.41 s. 9 H ((CHJjC); 2.30 br s, 2 H (CH2CH=CH2); 2.63 br s, 2 H (CH2CO); 
4.95 d, 1 H, J = 8.3 (c/s-CH2=CH); 5.02 d. 1 H, / = 16.8 (trans-CH2=CH); 5.15 s, 2 H 
(CH2COO); 5.81 br s, 1 H (CHttCHJ; 5.96 s, 2 H (ArCHJ; 7.72 d. 2 H, / = 7.9 (ArH); 8.19 d. 
2 H, J = 7.9 (ArH); 9.81 s, 1 H (H-8); 11.32 br s, 1 H (NH); 12.20 br s. 1 H (NH). , 3C NMR 
(decoupled and /-modulated spin-echo spectra): 27.45 (CfCHJJ; 28.22 (CH2CH=CH2); 35.29 
(CH2CONH); 45.99 (CH2COO); 50.36 (ArCHJ: 83.27 (C(CH3)3): 109.50 (C-5): 115.12 
(CH2=CH); 123.62 (ArCH); 129.26 (ArCH): 137.11 (CH2=CH); 138.99 (C-8); 142.06 (C-l', 
C-4'); 147.37 (C-2*); 148.30 (C-6*); 153.83 (C-4); 164.92 (COOt-Bu); 173.75 (C4H7CONH). 
MS (ESI), m/z (rel.%): 483 (100) [M*J. 
tert-Butyl [N2-(Pent-4-enoyl)guanin-9-yl]acetate (14) 
Sodium dithionite (0.790 g, 3.6 mmol, 80%) was added to a solution of guaninium salt 12 
(0.530 g, 0.94 mmol) in acetone (15 ml) and phosphate buffer (15 ml, pH 7.0). After 30 min 
stirring at room temperature, the solution was heated at 70 "C for 16 h. Acetone was evapo-
rated in vacuo and the water phase was extracted with EtOAc (50 ml). The title ester 14 
(0.250 g, 76%) was obtained as a yellowish amorphous solid. Rp 0.19 (S2). 0.22 (S3). UV: 
Xmm (50% (v/v) 1 M HC1 in EtOH, pH 0) 203 (4.22), 261 sh (4.03); Xmax (50% (v/v) 1 M T E A C 
in EtOH, pH 7) 260 (3.98), 280 (3.85); X ^ (50% (v/v) 0.1 M KOH in EtOH. pH 13) 267 
(3.89). 'H NMR: 1.40 s, 9 H (C(CH3)3); 2.33 q, 2 H. J = 7.0 (CH2CH=CH2); 2.56 t, 2 H. / = 7.2 
(CH2CO); 4.86 s, 2 H (CH2COO); 4.98 d, 1 H, / = 10.1 (c/s-CH2=CH); 5.05 d, 1 H, / = 16.3 
(trans-CH2=CH); 5.82 m. 1 H (CH=CH2); 7.94 s. 1 H (H-8); 11.66 br s, 1 H (NH); 12.04 br s. 
1 H (NH). 13C NMR (decoupled and /-modulated spin-echo spectra): 27.56 ((CH3)3C); 28.09 
(CH2CH=CH2); 34.98 (CH2CO): 44.76 (CH2COO); 82.24 ((CH3)3C); 115.49 (CH2=CH); 119.54 
(C-5): 136.74 (CH2=CH); 140.23 (C-8): 147.76 (C-2*); 148.85 (C-6*); 154.73 (C-4); 166.49 
(COOt-Bu): 175.50 (C4H7CONH). MS (ESI), m/z (rel.%): 717.41 (38) [2 M + Na]+, 695.43 (68) 
12 M + HP, 370 (18) [M + Na]\ 348 (100) [M + HP. 
This research has been supported by OTKA (¡pant T 22551) and EU FP6 (pant Targeting replica-
tion and integration of HIV. TRloH 503480). 
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A Regioselective Synthesis of Alkyl 
2-(Guanin-9-yl)acetates as PNA Bui ld ing 
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Derivatives 
Györgyi Ferenc, Péter Forgó, Zoltán Kele and 
Lajos Kovács 
O 
4 steps / / N~-|T vNH 
guanosine »• \ II I 
36% N - ^ N ^ M H P n t 
Y 
r-BuO 
Collect. Czech. Chem. Commun. (Vol. 69) (2004) 
III. 
RAPID COMMUNICATIONS IN MASS SPECTROMETRY F p J 
Rapid Commun. Mass Spectrom. 2005; 19: 1-5 m km. 
Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/rcm.l774 
Determination of A^/A^-isomer ratio of alkyl 
(guanin-9-yl)acetates by electrospray ionization 
tandem mass spectrometry 
Györgyi Ferenc, Zoltán Kele and Lajos Kovács* 
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Received 23 September 2004; Revised 11 November 2004; Accepted 11 November 2004 
/ - and / - S u b s t i t u t e d (guanyl)acetic esters were studied by electrospray ionization tandem mass 
spectrometry (ESI-MS/MS) in order to determine their ratio in alkylation reactions. The loss of 
ammonia is significantly different for the / - and / - a l k y l a t e d guanine regioisomer pairs. More 
importantly, the abundance of the [MH-17] 4 ion is in linear correlation with the / - i s o m e r content. 
Therefore, the ratio of regioisomers can be determined in a mixture containing these compounds. 
Copyright © 2004 John Wiley & Sons, Ltd. 
/ - S u b s t i t u t e d analogs of guanine nucleosides have been 
extensively investigated for their biological activity espe-
cially as anticancer and antiviral compounds.1 They are 
important as building blocks ((guanin-9-yl)acetic acid) of 
antisense and antigéné oligonucleotide analogs, e.g. peptide 
nucleic acids (PNAs).2 Unfortunately, the glycosylation and 
alkylation of guanine and related compounds, e.g. 2-amino-
6-chloropurine, is not regioselective, forming the unwanted 
/ - r e g i o i s o m e r s as side products.3 The yield of the product 
can be improved by optimization of reaction conditions, the 
effectiveness of which can be improved by a fast analytical 
method avoiding separation of regioisomers. The sensitivity 
of the method is also important in order to optimize the alky-
lation conditions on a few mg scale accompanied by a fast 
thin layer chromatography (TLC) purification. 
The site of the alkylation can be ascertained most 
conveniently by using two-dimensional nuclear magnetic 
resonance (2D-NMR) ( JH, 13C) techniques, but the chemical 
shift differences of some diagnostic 13C signals4 a n d / o r 
chemical shift of N-35 are also very informative. Unfortu-
nately, the latter two methods, unlike 3H NMR, give only 
qualitative information and at least 5 mg of pure solvent free 
sample is required, usually preceded by chromatographic 
purification (e.g. TLC). Both the purification and the NMR 
analysis take at least 10-20 min. Furthermore, expensive 
deuterated solvents are required for the latter procedure. 
High-performance liquid chromatography (HPLC) analy-
sis would be another possible approach but this should be 
preceded by NMR measurement to have a standard sample. 
Furthermore, a gradient system for the separation of 
regioisomers is required and a HPLC run takes 10-20 m i n / 
*Correspondence to: L. Kovács, Department of Medicinal 
Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, 
Hungary. 
E-mail: kovacs@ovrisc.mdche.u-szeged.hu 
Contract/grant sponsor: EU; contract/grant number: TRIoH 
503480. 
sample, (thus in the case of 10 parallel reactions 100-200 min) 
and a large volume of high purity solvent. This is not the case 
with a tandem mass spectrometry (MS/MS) method, in 
which a few pL of test reaction mixture is sufficient after 
dilution. The criteria of the applicability are a significant 
difference in the fragmentation pathways of the two regio-
isomers and a product ion whose abundance is proportional 
to the ratio of the isomers. Details of the derivatives of / - and 
/ - a l k y l a t e d guanine derivatives studied by MS/MS are 
collected in Table 1. 
Usually, / - and / -isomer pairs are identified by their 
product ion spectra but in some cases there is only a slight 
difference between the spectra. The most unambiguous 
differentiation between 9- and 7-methylguanines was achiev-
ed by chemical ionization (CI)-MS/MS using NH 3 as the CI 
gas in which the loss of CH3NH2 was characteristic exclusively 
for the / - i s o m e r . 6 In the case of /1-O-activated alkyl groups, 
e.g. CH2OCHR1R2, the abundance of ions derived from the 
side chains was much higher for the / - i s o m e r . Therefore, the 
identification was based on this fact.10 These studies have, 
however, afforded only qualitative information. 
The fragmentation of the protonated guanine backbone was 
confirmed by 15N and 1 6 0 labelling13 and H / D exchange,12 
proving that losses of ammonia and cyanamide are indepen-
dent and principal pathways, followed by loss of CO and HCN. 
(/-Acyl-guanin-9-yl)acetic esters 1 (9IbuMe),3 (9IbutBu)4 
and 5 (9PnttBu)14 have been synthesized in our laboratory as 
PNA monomer building blocks and studied by electrospray 
ionization tandem mass spectrometry (ESI-MS/MS) along 
with their / - r e g i o i s o m e r pairs 2 (7IbuMe) and 4 (7IbutBu), 
respectively4 (Fig. 1). The side chain of these compounds is an 
acetic ester derivative, which is different from those pre-
viously studied. It is therefore interesting to consider how 
this will influence the fragmentation of the regioisomers. Our 
aim was to determine the / / / - i s o m e r ratio by a simple and 
time- and cost-effective MS/MS method finding optimal 
collision-induced dissociation (CID) conditions where a 
Copyright © 2004 John Wiley & Sons, Ltd. 
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Table 1. Structures of alkylated guanine derivatives studied 
by MS/MS (CI-MS/MS,6 ESI-MS/MS,7,12 FAB-MS/MS8"11) 
methods 
RCM 
Alkyl side chain® The site of the alkyl group" 
Me,6"8 Ht,8 I V 7 6-9 (j6 8 
C H j C R H O H ; R = H, CH3 , C H 2 O H •f 
CH 2 OCH 2 CH 2 OR; R = H, AC 7, 1 0 , " 9,10,11 91 2 (R = H) 
CH 2OCH(CH 2OR) 2 ; R = H, Bn 711 9 n 
a Refs. in superscripts. 
significant difference can be observed in the f ragmenta t ion of 
regioisomers. 
E X P E R I M E N T A L 
Mass spectrometr ic measu remen t s were obtained on a 
Finnigan TSQ-7000 triple q u a d r u p o l e mass spectrometer 
(Finnigan-MAT, San Jose, CA, USA) equ ipped with a Finni-
gan ESI source. The ins t rument w a s scanned in positive ion 
m o d e over the mass range m/z 160-230 with a scan t ime of 
0.1 s. Samples of 5 pL were injected into the eluent s t ream of 
a p u m p (Applied Biosystems 140 C (Foster City, CA, USA); 
flow rate: 1 5 0 p L / m i n , eluent: m e t h a n o l / w a t e r / a c e t i c acid 
50:50:1 ( v / v / v ) , s ample concentration: 0.1 m g / m L ) . 
The electrospray needle was ad jus ted to 4.5 kV and N 2 
(pressure: 3.45 bar) was used as the nebulizer gas. The 
collision energy was varied be tween - 1 0 and - 7 0 e V to find 
the optimal value ( - 3 5 eV for c o m p o u n d s 1 (9IbuMe) a n d 2 
(7IbuMe); - 4 5 eV for c o m p o u n d s 3 - 5 (9IbutBu, 7IbutBu and 
9PnttBu)). At this value the abundance of the [ M f + H ] + ion 
was 100% and that for the [ M f + H - 1 7 ] + ion was almost the 
same. The collision gas w a s argon and the pressure in the 
collision cell region was set at 2 ± 0.1 mTorr . 
R E S U L T S A N D D I S C U S S I O N 
Our c o m p o u n d s (see Fig. 1) conta ining dif ferent N2-acyl pro-
tecting g roups (isobutyryl in 1 (9IbuMe), 2 (7IbuMe), 3 (9Ibut-
Bu), a n d 4 (7IbutBu) and pent-4-enoyl in 5 (9PnttBu)) a n d 
alkyl moieties in ester g roups (methyl in 1 (9IbuMe) a n d 2 
(7IbuMe) and ferf-butyl in 3 (9IbutBu) and 4 (7IbutBu)) could 
give use fu l informat ion on whether these g roups have an 
effect on f ragmenta t ion pa thways . The loss of the feri-butyl 
V —o 
tó 
A . X 
N N 
1 (9lbuMe) 
0 
C12H15N5CU 
[M+H]*= 294 
/ , - Í NH 0 
t K y y 
2 (7lbuMe) 
/ ; T: NH O K»J A U 
r V N r 
3 (9lbutBu) 
i f " 
/> ~RR NH O 
, U A A 
y j « 
5 (9PrttBu) 
C15H21N5O4 
[M+H]*= 336 
C,7H23NE04 
[M+H]*= 362 
W v 
4 (7I butB u) 
Figure 1. Structures of alkyl 2-(guanin-yl)acetates (1-5 , 9lbuMe-9PnttBu) 
studied by ESI-MS/MS. 
[1+H]+ -
[3+H]+-
[5+H]+-
V 
- o 1f(9Me) 
NH 
A 
N NH, 
V 
NH 
C8H1DN503 
[M,]*- 224 
C 7 H 8 N 5 0 3 
[Mf]+= 210 
<r*V I 
2f (7Me) 
[2+H]+ 
A x i " 
<uT X 
3f (90H) 
o 
NH 
NH2 
4f (70H) 
1. B 
2. A 
(4+H]+ 
Figure 2. Structures of compounds 1f (9Me), 2f (7Me), 3f (90H) and 4f 
(70H) formed from alkyl 2-(guanin-yl)acetates (1 - 5 ) in MS/MS experiments at 
- 3 0 eV. Process A: deacylation of the / / -amino group, process B: hydrolysis 
of the feri-butyl ester. [M (]+ denotes the m/z value of the product ion (1f-4f). 
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1f and 3f 
- C O 
- C H 3 O H a o r - H 2 O b 
m/z 1 6 4 
m/z 1 2 2 
Figure 3. Formation and fragmentation of the ion at m/z 164 
(a) from compounds 1f (9Me) and 2f (7Me); and (b) from 
compounds 3f (90H) and 4f (70H). 
ester (Fig. 2, process B) was fol lowed by dissociation of the 
N2-acyl g r o u p (Fig. 2, process A). Thus the difference caused 
by these g roups d i sappeared to such an extent that corn-
Determination of bP/N7-isomer ratios of alkyl (guanin-9-yl)acetates 3 
2f and 4f p o u n d s 3 (9IbutBu) and 5 (9PnttBu) led to the s ame acid 3f 
(90H) . Therefore, the f ragmenta t ion of di f ferent ly protected 
c o m p o u n d s was similar. The f ree acid fo rm (3f ( 9 0 H ) and 4f 
(70H)) rendered the s ide chains uns table at higher energies 
in an M S / M S s tudy . 
The p roduc t ions If (9Me), 2f (7Me), 3f ( 9 0 H ) and 4f ( 7 0 H ) 
were the most a b u n d a n t at — 30 eV collision energy (for 
s tructures, see Fig. 2). The l f - 4 f ions are precursors of lower 
mass p roduc t ions; therefore, the fur ther f ragmenta t ion s teps 
can be more easily compared if w e der ive them f rom the f 
series (m/z values of the f series are indicated by [M f]+). 
The major f ragmenta t ion pa thways (losses of a m m o n i a 
and cyanamide) of ions If (9Me), 2f (7Me), 3f ( 9 0 H ) and 4f 
( 7 0 H ) are in good agreement with observat ions by Gregson 
and McCloskey1 3 and Kamel and Munson . 1 2 Losses of 
methanol (If (9Me), 2f (7Me)) or water (3f ( 90H) and 4f 
(70H)) and carbon monoxide also occurred, d e p e n d i n g on 
the na ture of s ide chain, leading to the ion at m/z 164, the 
rear rangement of which to pter ine w a s suggested by Kralj 
et al}° (see Fig. 3). The m/z 164 ion loses N H 3 and cyanamide , 
as do the precursor ions (If (9Me), 2f (7Me), 3f ( 9 0 H ) and 4f 
(70H)) , to yield ions at m/z 147 and 122, respectively. 
When compar ing the M S / M S spectra of c o m p o u n d s 1 
(9IbuMe), 2 (7IbuMe), 3 (9IbutBu) and 4 (7IbutBu), it was 
found that, in both cases, the N9-isomers (1 (9IbuMe) and 3 
(9IbutBu)) gave abundan t [ M f - N H 3 ] + ions at m/z 207 a n d 193 
that were of negligible abundance in the case of the N7-isomers 
(2 (7IbuMe) and 4 (7IbutBu)) (see boxes in Fig. 4). Therefore, 
the loss of ammonia f rom the Mf ions is a potential candidate 
for the quanti tat ive determinat ion of the regioisomer ratio. 
Figure 4. MS/MS spectra of regioisomer pairs 1 (9lbuMe), 2 (7lbuMe) and 3 (9lbutBu), 4 
(7lbutBu) studied. The loss of ammonia, the most important fragmentation pathway, is 
highlighted by boxes. Other important peaks are labelled as follows: *: [M,-42]+, #: m/z 
164 (for structure, see Fig. 3) and @: m/z 152. m/z 179 is also framed as it could be 
potentially interesting in future studies of A/7-isomers. 
Copyright © 2004 John Wiley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2005; 19: 1-5 
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Table 2. Ions of compounds 1 (9lbuMe), 2 (7lbuMe), 3 (9lbutBu) and 4 (7lbutBu) and their masses based on studies by 
McCloskey et al.13 and Kamel et al,12 Compounds 1 f -4f (Fig. 2) originate from initial fragmentation of compounds 1 - 5 
[substances 3 and 5 gave an identical acid (3f)] The most important, deammoniated fragment (set in bold) was applied for the 
determination of isomer ratio. Structures of ions corresponding to italicized and underlined peaks have not been confirmed. The 
underlined one could be important for the characterization of A/7-isomers but further studies are required 
If (9Me), 2f (7Me) ((M,]+ = 224) 3f (90H), 4f (70H) ([M,]+ = 210) 
Product ion Precursor ion Mass difference Fragment(s) lost Product ion Precursor ion Mass difference Fragment(s) lost 
207 224 17 NH, 193 210 17 NH3 
192 224 32 MeOH 168 210 42 NH2CN 
182 224 42 NH2CN 164 210 46 H2O+CO 
179 207 28 CO 152 210 58 C2H2O2 
164 224 60 MeOH+CO 149 193 44 C02 
150 182 32 MeOH 147 164 17 NH3 
147 164 17 NH3 135 152 17 NH3 
137 164 27 HCN 124 152 28 CO 
124 151 27 HCN 119 147 28 CO 
122 164 42 NH2CN 110 152 42 NH2CN 
121 164 43 NHCO 
119 147 28 CO 
94 122 28 CO 
100 
40 60 80 
100 x [N9/(N9+N7)] [%] 
1 0 0 
Figure 5. The linear regression study of product ion 
abundance as a function of isomer ratio in a mixture 
containing compounds 3 (9lbutBu) and 4 (7lbutBu). + series: 
m/z 193; x series: m/z 168 and o series: m/z 164. 
The m/z 179 ion in the spec t rum of c o m p o u n d 2 (7IbuMe) is 
interesting as it could be a p roduc t of m/z 207 formed by loss of 
CO. This ion could be characteristic for the N7-isomer but 
fur ther s tudies are required involving other alkyl (guanin-9-
yDacetates containing stable ester bonds . 
The a b u n d a n t ion at m/z 152, cor responding to pro tonated 
guanine , is the result of total side-chain loss f rom the free acid 
form of 3f ( 9 0 H ) a n d 4f (70H) . This ion then loses N H 3 , C O 
and cyanamide to yield ions at m/z 135, 124 and 110, 
respectively. 
The N9- isomer 3f ( 9 0 H ) gives a characteristic loss of 
ammonia as the parallel process of the side-chain loss; there-
fore, the ratio of regioisomers can also be de te rmined in the 
case of ferf-butyl esters. 
It appears conclusive that the loss of ammonia is charac-
teristic for /V+regioisomers (1 (9IbuMe) and 3 (9IbutBu)). 
Next, the abundance of the [ M r 1 7 ] + ion as a funct ion of 
regioisomer ratio w a s s tud ied . 
The f ragmentat ion pa thways conf i rmed by Gregson 
McCloskey1 3 and Kamel and Munson 1 2 have been collected 
in Table 2 for easier interpretat ion of M S / M S spectra 
described herein. 
A series of solutions containing the isomers in di f ferent 
ratios has been s tudied by M S / M S in o rder to obtain a 
calibration curve. The abundances of the three main p roduc t 
ions, [Mf-17]+, [ M r 4 2 ] + and m/z 164, were plot ted as a 
function of the isomer ratio (see Fig. 5). The correlation w a s 
linear in all three cases bu t with different slopes. The 
abundance of the ion [ M r 4 2 ] + is a lmost constant; fur ther -
more, its correlation coefficient (R2) value shows large 
uncertainty for c o m p o u n d s 3 (9IbutBu) and 4 (7IbutBu) (see 
Table 3). It is not therefore appropr ia te for the de terminat ion 
of the isomer ratio. 
Based on their high correlation coefficients (see Table 3), 
the abundances of ions [ M r 1 7 ] + and m/z 164 are both 
convenient for the determinat ion of isomer ratios; however , 
Table 3. Correlation coefficient (R2) values from linear regression analysis of the abundances of three ions ([M,-17]+, [M,-42]4 
and m/z 164 (for structure, see Fig. 3)) as a function of the regioisomer ratio for both pairs of regioisomers 
Sample constituents [M r 17] + R2 [M r42]+ R2 R2 for m/z 164 
1 (9IbuMe), 2 (7IbuMe) m/z 207 0.997 m/z 182 0.981 0.994 
3 (9IbutBu), 4 (7IbutBu) m/z 193 0.995 m/z 168 0.875 0.996 
Copyright © 2004 John Wiley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2005; 19: 1-5 
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Table 4. Error of the measurement based on two points: 50 
and 90% Af-isomer content. y = the measured relative 
abundance of the ion [M,-17]+; x = the determined value of 
the isomer ratio; e.g. x = (y - 3.28)/0.75 for compounds 1 
(9lbuMe) and 2 (7lbuMe). Error: the relative error of the 
determination; 5x=(x-xc)/xc 
0 2 0 4 0 SO 8 0 1 0 0 
100 X [N9/(N9+N7)] [%] 
Figure 6. Calibration at two different CID gas pressures of 
compounds 1 (9lbuMe), 2 (7lbuMe) at 2.1 mTorr (o series, 
y = 4.68 +0.71 x, R2 = 0.997) and 1.7 mTorr (x series, 
y = 4.45 + 0.60x, R2 = 0.997). 
as the change in abundance is twice as large for the [M r 17] + 
ion than for m/z 164, its application would lead to more 
accurate results. The optimal collision energy at which the 
abundance of the [Mf-17]+ ion is similar to that of the [M f]+ 
ion for the N9-isomer and negligible for the N7-isomer (less 
than 10% relative abundance) is also important for the same 
reason. 
The slope of the calibration curves depends strongly on the 
collision gas pressure (see Fig. 6). Therefore, the CID pressure 
should be adjusted accurately to obtain comparable ion 
abundances. For example, a change of 0.4 mTorr led to a 
0.1 difference in the slope, meaning that the relative 
abundance of the [M r 17] + ion changed ca. 10% in the case 
of the pure N 9 -isomer. This problem is increased for 
compounds 3 (9IbutBu) and 4 (7IbutBu), resulting in a 20% 
change in abundance (data not shown). To obtain accurate 
results every isomer determination should start with a 
calibration (maximum 15 min) to guarantee identical condi-
tions in the analysis. 
Alternatively, the calibration before each analysis could be 
avoided by use of a normalization based on an ion whose 
abundance is independent of the isomer ratio. Unfortunately, 
there was no such ion in the m/z 160-230 range. 
The accuracy of the measurement is ca. 2.2-4.4% (1 
(9IbuMe) and 2 (7IbuMe)) and 4.8-5.0% (3 (9IbutBu) and 4 
(7IbutBu)) depending on the isomer ratio (Table 4). These 
values are acceptable as the aim of the optimization of 
reaction conditions is to increase the /V-isomer content from 
ca. 50% to 90-100%. Almost the same accuracy could be 
achieved with 'H NMR but this latter method requires 
cleaner and larger amounts of sample, deuterated solvents 
and 10-20 m i n / s a m p l e acquisition time. If the isomers were 
well resolved by HPLC then higher accuracy could be 
obtained, but even then there is a need for high-purity 
solvents and again 10-20 min / s amp le analysis time. 
1 (9IbuMe) and 
2 (7IbuMe) [%] 
3 (9IbutBu) and 4 
(7IbutBu) [%] 
x c 50 90 50 90 
y 393 69.3 51.2 81.1 
X 47.8 88.0 52.5 85.7 
lOOáx -4.4 -2.2 5.0 -4.8 
Calibration curves y = 3.28 + 0.75x y = 3.99 + 0.9x 
CONCLUSIONS 
In conclusion, we have managed to find a rapid method for 
the determination of the ratio of regioisomer pairs of alkyl 
(guanin-9-yl)acetates. Alkylated N9- and N7-regioisomer 
pairs have significantly different fragmentation pathways: 
deammoniat ion is characteristic for N9-isomers, the abun-
dance of which process is in linear correlation with the N9 
content in a mixture of regioisomers. 
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The optimization of PNA oligomer synthesis has been accomplished employing Fmoc/acyl-protected monomers on 
TentaGel™ and Wang resins. Among the tested activating agents (CMP, BET, H ATU) the latter was of choice in 
solid phase syntheses. "Leakage" of TentaGel™ resin greatly hampers the solution and MS analyses. Synthesis and 
acyl group deprotection steps have been separately examined using Wang resin. Optimal conditions also worked well 
on the CPG support. HPLC and MS analyses of the PNA oligomers were carried out under various conditions. 
Introduction 
Peptide nucleic acids (PNA) are important tools in molecular 
biology and in drug design owing to their antisense and 
an ti gene effects.1-4 They have the advantage of greater in vivo 
stability and stronger hybridization ability in comparison with 
native oligonucleotides. However, they enter less easily into 
the cells and cell nuclei and have low RNAseH activity. PNA 
conjugates incorporating peptides,5 oligonucleotides,6-9 carbo-
hydrates10 or lipophilic molecules,11 respectively, might be con-
sidered as possible solutions for the above problems. 
In order to synthesize PNA oligomers and their conjugates 
with peptides or oligonucleotides, suitably protected monomers 
are indispensable and they have to be compatible with both 
peptide and oligonucleotide synthesis protocols. To date this 
problem has not been solved as shown in Table 1. The mono-
mers protected by Fmoc (backbone) and acyl (nucleobase) 
groups (Fig. I)12 could fulfil the requirements of PNA-oligo-
FmocHN 
Table 1 Compatibility of protecting group strategies with peptide and 
oligonucleotide protocols 
Ba Thy 4 ,BuBzCyt AnAde lbuGua 
Code" t c a g 
Fig. 1 The structure of Fmoc/acyl-protected peptide nucleic acid 
(PNA) monomers, a. Thy: thymin-l-yl, <-,B"BlCyt: JV4-(4-ierf-buty-
lbenzoyl)cytosin-l-yl, A"Ade: A r '-anisoyladenin-9-yl, Ib"Gua: JVMso-
butyrylguanin-9-yl. b. Abbreviated notation of unprotected or 
protected monomer units, depending on the context. 
nucleotide conjugate synthesis. This combination of protecting 
groups has not been thoroughly explored,13-17 the advantages 
and pitfalls have not been characterized in detail. There are a 
few reports on optimization of PNA oligomer syntheses,15,18-22 
however, there are so many variables affecting the effectiveness 
of the synthesis (nature of solid supports and monomers 
including the protecting groups of the latter, coupling reagents 
and conditions e.g. bases, preaetivation, reaction time, mixing 
sequence, monomer excess, repetition of couplings etc.) that it 
is impossible to simply establish the optimal conditions for the 
preparation of PNA oligomers. The present report describes 
our efforts directed towards the elaboration of a PNA oligomer 
Protecting groups4 Compatibility 
Boc/Cbz'(Benzyl) 
Fmoc/Cbz4 
Fmoc/Bhoc ' 
Fmoc /Mmt 4 
Fmoc/acyl 
MmC/acyl 
Peptide 
Peptide 
Peptide 
Peptide 
Oligonucleotide 
Oligonucleotide 
° The first abbreviation denotes the protecting group of the backbone 
while the second one that of the nucleobase.4 Cbz: benzyloxycarbonyl. 
c Bhoc: benzhydryloxycarbonyl. d Mmt: monomethoxytrityl. 
synthesis protocol convenient for the synthesis of PNA-
oligonucleotide conjugates and their HPLC and MS analysis. 
This paper complements and details our preliminary account 
on this subject.23 
Results and discussion 
1. Coupling experiments in the solution phase 
For the efficient coupling of PNA monomers, an activating 
agent is required which works quickly with the lowest possible 
monomer excess, gives high yields and is economically viable. 
BET24 and CMP2 5 gave almost quantitative yield while HATU 
gave only 90% yield in solution phase studies in the model reac-
tion between our t monomer and tert-butyl phenylalaninate.26 
2. Initial coupling studies on the solid phase 
A solid phase compatible with peptide and oligonucleotide 
synthesis protocol was needed for PNA oligomer synthesis. 
Polyfethylene glycol) attached to polystyrene (known as 
TentaGel™) meets the above criteria and the removal of pro-
tecting groups and final cleavage from the support can be 
realized also in one step.27 
In the following experiments coupling yields were determined 
by UV absorbance of dibenzofulvene-piperidine adduct. 
2.1. CMP and BET. Surprisingly, these activating agents 
gave low yields in solid phase coupling reactions. Thus, they 
were no longer utilized in further studies. The reasons of this 
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Table 2 Coupling yields (%) on TentaGel™ resin using 4 equiv. 
monomer excess" 
a 100 
c 83, 100, 86 
g 100 
t 100 
92 
93, 100, 89 
100,93,100 
97,88 
98,100 
96 
91,91 
92, 83 
99, 100, 100 
100 
100, 100, 100 
97, 97, 98 
" Data taken from the synthesis of sequences 1 -4 (cf. Table 4). Mono-
mers (rows) were coupled to the monomers on the resin (columns). 
discrepancy between the solution and solid phase experiments 
are currently still under investigation. 
2.2. HATU. During the synthesis of the first sequences on 
FmocGly-O-TG resin 2 equiv. of monomer was not sufficient 
even after prolonged reaction time thus the excess was increased 
to 4 equiv. resulting in 95% average yield (Table 2). When the 
monomers were coupled to t the yield was almost quantitative 
in all cases. The reactions c + a and t + g were the lowest 
yielding (<90%) while couplings to c or g monomer were in the 
91-96% range. 
3. Problems with the PNA oligomer synthesis on TentaGel™ 
The synthesis runs smoothly according to the UV absorbances 
but there is a problem with the solubility of the product, con-
sequently also with its analysis, and this problem was increased 
with the length of oligomer. 
3.1. Ethylene glycol oligomers in the ESI-MS spectra. In the 
ESI mass spectra of PNA oligomers with different chain 
lengths synthesized on TentaGel™ a series of peaks corre-
sponding to the cluster ions [H0(CH2CH20)„H + 2NH4]2+ was 
observed. This process can be the result of decomposition of 
the resin during storage, however, the above peaks were present 
even after thorough washing. The fracture of TentaGel™ beads 
resulting in the release of oligo(ethylene glycol) fragments 
("leakage" of the support) has been a known phenomenon,27 
however, there are no reports on the fact that this would inter-
fere with the synthesis of oligomers. Probably, the "leakage" 
causes problems only if the synthesis is performed on a low 
scale. 
Ofigo(ethylene glycol) chains make the spectra rather noisy 
but applying the nano-ESI technique28 a clear spectrum is 
observable most likely due to separation inside the gold-coated 
capillary tube of the nano-ESI-MS interface as is represented 
by the mass spectra of TI-Gly-ggtt-Gly-NH2 (compound 3, 
Fig. 2). The attempted purification of PNA samples by precipi-
tation to separate them from the contaminating oligo(ethylene 
glycol) was not successful. 
3.2. Incomplete removal of isobutyryl (Ibu) protecting groups 
(presence of [M + 70 + II]+ peaks). Capped (e.g. Ac-gtt-Gly-
NH2) and incompletely deacylated sequences (e.g. peaks [M + 
Ibu + H]+) were also present in the MS spectra beside the 
expected product (Fig. 2, lower panel). To determine the 
ratio of capped, protected sequences to that of the product an 
HPLC analysis was needed whereby these compounds could 
be separated. In order to separate the coupling and acyl depro-
tection steps, the polystyrene-based, acid sensitive Wang resin 
was employed because the protected oligomer can be cleaved 
with TFA and the acyl group deprotection can be realized by 
N H j treatment in solution. 
4. Syntheses on Wang resin 
Similar results were obtained with 4 equiv. monomer excess 
during the synthesis of test sequence l.18 As a compromise 
between monomer excess and coupling efficiency, compound 
5 was synthesized using 3 equiv. of monomers resulting in 
# 978.7)080.0 
Fig. 2 Mass spectra of PNA oligomer 3 (McaIe 1245) synthesized on 
TentaGel™. Upper panel: ESI-MS spectrum. The values marked with 
an asterisk denote the cluster ions [H0(CH 2 CH 2 0)„H + 2 N H J 2 + . 
Lower panel: nano-ESI-MS spectrum. Peaks denoted with # and $ signs 
correspond to the ions [Ac-gtt-GlyNHj + H]+ and [M + Ibu + H]+ , 
respectively. 
98% average yield per cycle and HPLC chromatogram of the 
products (Fig. 3) confirmed that this excess is optimal. It 
is noteworthy that the highest ever reported coupling yield 
(99.4%) was achieved at the expense of 7-fold monomer 
excess.19 
To find appropriate HPLC conditions for separation of 
the product from capped sequences and anisoyl derivatives 
(An-X, X = NH2, OH originating from the protecting group) 
the solution of oligomer 5 was analyzed on different HPLC 
column packings in order to examine the effects of pH of the 
eluting solution (TEAA, pH 7.0 or dilute TFA, pH ~ 2) and 
temperature (rt or 55 °C) on the resolution (Table 3 and Fig. 4). 
TFA buffer gives better resolution than TEAA as exemplified 
by the separation of pentadecamer 5 on LiChrospher RP Select 
B column (Fig. 4, traces A and B). Apparently, this molecular 
size does not require 300 A pore size for an efficient separation. 
For shorter sequences better resolution was observed on 
Jupiter packing with very sharp peaks. However, for longer 
sequences the product and the anisoyl derivatives could not be 
separated on this packing (Fig. 4, trace C). The separation was 
good on the less apolar Vydac column as well but in this case 
the peaks were broader than on other column packings (Fig. 4, 
trace D). The retention times were very similar on the above-
mentioned packings in TFA solution. The effect of tempera-
ture29,30 was also studied, however, there was no significant 
improvement in the resolution therefore further separations 
were carried out at room temperature. In conclusion, the 
LiChrospher RP Select B column using a TFA-containing 
eluent provides the optimum conditions for PNA analysis and 
purification. 
Oligomers 3, 4, 6-8 (Table 4) were synthesized to check the 
completeness of protecting group removal (it is well known that 
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Table 3 Comparison of analytical HPLC columns and conditions applied in the analysis of PNA oligomers 
Column name" Pore size (A) Reverse phase type End-capping Eluent ' f R ' ( m i n ) 
Jupiter2 300 CI 8 Yes TEA ' 17.2 
Vydac2 300 C4 —•1 T F A ' 16.3 
LiChrospherRP Select B ' 60 CI8 Yes T F A ' 17.6 
TEAA' 20.9 
" Size of columns: 250 x 4.6 mm. ' Principal component of buffer . ' Retention time of compound S at 25 °C. 2 Phenomenex, Torrance, CA, USA. 
' 0 .1% (v/v) Trifluoroacetic ac id . 'The Separations Group, Grace Vydac, Hesperia, CA, U S A . 1 Data not available.' Merck Ltd. Budapest. '0.1 M 
Triethylammonium acetate. 
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Fig. 3 Upper panel: HPLC chromatogram of the PNA sequence 5 
prepared on a Wang resin (crude product, LiChrospher RP Select B 
column, TFA-containing eluent). Peak a: product, peak c: anisoyl 
derivatives, peaks b and d: unidentified. Lower panel: ESI mass 
spectrum (purified product, Mcdc 4284). 
9 15 TR/MIN 21 
Fig. 4 HPLC chromatograms of the crude oligomer S under different 
conditions. Trace A: LiChrospher RP Select B column, TFA eluent; 
trace B: LiChrospher RP Select B column, TEAA eluent; trace C: 
Jupiter column, TFA eluent; trace D: Vydac column, TFA eluent. Peak 
a: product, peak c: anisoyl derivatives, peaks b and d: unidentified. 
(cf. Table 3). 
in oligonucleotide synthesis the rate of deprotection decreases 
in the order 4-tBuBz > An > Ibu).31 
The removal was complete in the case of anisoyl and 4-tert-
butylbenzoyl groups but a small amount of oligomers contain-
ing residual isobutyryl groups were detected (Fig. 5). 
When the deprotection time was elongated for 48 h the 
6 0 0 • 
400 • 
e 
° 200 
0 5 10 15 20 
Wmin 
Fig. 5 HPLC chromatogram (Vydac column, TFA-containing eluent) 
of a crude PNA oligomer (peak a: compound 8) after detachment from 
the support (Wang resin) and deprotection. 
oligomer decomposed. The exocyclic amino group of cytosine 
with other bases (eg. primary amines) can be converted to the 
corresponding amine." Indeed, n-butylamine, hydrazine or 
diethylamine furnished complex product solutions even after 
prolonged reaction times. Thus, the routinely applied ammonia 
solution was used for cleavage as no better one was found. 
5. Synthesis on CPG 
In order to prepare ON-PNA conjugates Wang resin is not an 
appropriate support for automated O N synthesis, thus we have 
turned to controlled pore glass (CPG) that is usually employed 
for this purpose. 
Nonamers 9, 10 and 11 were prepared on Fmoc-Gly-BzC-
CPG under conditions optimized earlier, where 2'-deoxy-
cytidine unit (B2C) is a kind of linker that was sacrificed during 
the cleavage. The HPLC chromatogram of the crude product 9 
shows that the synthesis runs smoothly as was expected based 
on UV absorbances (Fig. 6). Surprisingly, both the ESI- and 
MALDI MS spectra of the crude product were too noisy due to 
the capped sequences that were present in low concentration 
based on HPLC analysis. The unambiguous identification of 
the product was achieved by MALDI-TOF analysis of the 
purified sample. 
The C terminus of this substance is in both carboxy and 
carboxamide forms as can be seen from the isotopic pattern 
distribution in the MALDI-TOF-MS due to its high sensitivity. 
The molecular ions [M + H]+ and [M - H]_ were observed 
both in positive and negative modes which is also indicative of 
the presence of carboxy C terminus. 
Conclusion 
The synthesis of PNA oligomers has been elaborated using 
Fmoc/acyl-protected monomers. Although among the three 
activating agents (HATU, CMP, BET) the latter two were more 
effective in solution phase experiments the first one proved to be 
the best on the solid phase. Due to the "leakage" of TentaGel™ 
the product was contaminated and this rendered the mass 
spectrometry analysis difficult. The coupling and protecting 
group removal steps have been studied separately on Wang 
resin. Some isobutyryl group-containing PNA sequences 
remained in negligible amount with the classical (25% aq 
NH3 ,50 °C, 16 h) cleavage condition. 
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Table 4 PNA sequences synthesized and MS data 
Sequence" Mc l lc Peaks observed ( E S I - M S / 
H-Gly-cgg act aag toe att gc-Gly-NH2 (1) ' 4714 -
H-Gly-ag tcc att gc-Gly-NH2 ( 2 / 2814 - d 
H-Gly-ggtt-Gly-NH2 (3) ' 1245 1 245.8 [M + H]+; 623.6 [M + 2H]2+ 
H-Gly-aacc-Gly-NH2 ( 4 / 1183 1184.2 [M + H] ' , 592.9 [M + 2H]2 t 
H-Gly-gaa cat cat ggt cgt-Lys-OH (5) ' 4284 2144.0 [M + 2H]2 t ; 1430.0 [M + 3H]'+ ; 1072.0 [M + 4H]4 t 
H-Gly-a-Gly-NH2 (6)" 406 406.9 [M + H]+ 
H-Gly-g-Gly-NH2 (7) ' 422 423.0 [M + H]+ 
H-Gly-gj-Lys-OH (8) ' 1658 1657.7 [M + H]+; 830.3 [M + 2H]2+ 
Ac-cat ggt cgt-Gly-NH2 ( 9 / 2565 2565.97 [.M + H]+; 1283.48 [M + 2 H f \ 8 5 6 . 1 5 [M + 3H]J+ 
H-Gly-cat ggt cgt-Gly-NH2 ( 1 0 / 2580 2581.28 [M + H]+; 1291.08 (M + 2H)2* 
H-cat ggt cgt-Gly-NH2 ( 1 1 / 2523 2524.03 (M + H]+; 1262.5 [M + 2H]2+ 
" PNA oligomer (one-letter lower-case abbreviations) and amino acid (three-letter codes) sequences have been depicted from N to C termini. C 
termini of PNA oligomers cleaved from the support with aq. NH 3 solution are both in carboxamide and carboxy forms but for simplicity only the 
former one is deno ted . ' Peaks obtained with the ESI technique are given for the most intensive monoisotopic peaks. For MS spectra obtained with 
the MALDI technique (compounds 9 11) the values are given for the smallest monoisotopic peak. ' Synthesized on TentaGel™ S - O H 130 resin. 
d Obscured by oligo(ethylene glycol) fragments . ' Synthesized on Wang resin.1 Synthesized on CPG support. 
800 1100 1400 1700 2000 2300 2600 
m/z 
Fig. 6 Upper panel: HPLC chromatogram of the PNA sequence 9 
prepared on a CPG support (crude product, LiChrospher RP Select B 
column, TFA-containing eluent). Peak a: product, peak c: anisoyl 
derivatives, peak b: 2'-deoxycytidine Lower panel: MALDI mass 
spectrum (purified product, Afc>k. 2565). Inset: isotopic distribution 
of the molecular ion. 
The PNA oligomer synthesis runs smoothly on CPG and this 
support is a promising candidate for the preparation of 
oligonucleotide PNA conjugates with a suitable linker. 
The best HPLC resolution of oligomers could be achieved 
with TFA solution on a LiChrospher RP Select B column. 
In our experience it is not worthwhile to measure mass 
spectra of the crude samples because these spectra are rather 
noisy from the capped sequences even if the latter are present in 
low concentration. 
Our Fmoc/acyl-protected PNA monomers, with certain 
limitations, can successfully be applied in the preparation of 
PNA oligomers and their conjugates. Alternatively, other 
possible methodologies should be evaluated for nucleobase 
deprotection and consecutive detachment from the solid 
support. Studies addressing these issues are in progress. 
Experimental 
General 
Abbreviations: controlled pore glass (CPG); TentaGel™ S-OH 
130 (TG-OH); triethylammonium acetate (TEAA); retention 
time (zR); 2-(7-aza-l//-benzotriazol-l-yl)-l,l,3,3-tetramethyl-
uronium hexafluorophosphate (HATU); AA-diisopropyl-
ethylamine (DIPEA); 2-bromo-3-ethylthiazolium tetrafluoro-
borate (BET); 2-chloro-l-methylpyridinium iodide (CMP, 
Mukaiyama reagent). TG-OH was obtained from Merck 
(catalogueno. 814786, capacity: 0.2-0.3 mmol g"', particle size: 
130 pm), 500 A CPG (-40 pmol g"1) preloaded with 2'-
deoxycytidine from ChemGenes Corporations (Ashland, MA, 
USA), whereas HATU was from PE Biosystems (Warrington, 
UK.). Other chemicals were purchased from Aldrich, Fluka, 
Merck or Bachem. Anhydrous solvents were prepared as 
described.32 DMF refers to an anhydrous solvent, and lutidine 
to the 2,6-isomer. HPLC chromatography was performed on an 
HP1050 (room temperature) or on an HP 1090 (55 °C) or on a 
Shimadzu LC 10 (in case of compounds 9-11) instruments 
under the following conditions: (a) column packings: Rutin RP 
column CI8, 300 A, 250 x 4 mm (supplier: BST Ltd. Budapest, 
Hungary), LiChrospher RP Select B column C18, 60 A, 250 x 
4 mm (supplier: Merck Ltd. Budapest, Hungary), Vydac C4, 
300 A, 250 x 4.6 mm, Jupiter CI8, 300 A, 250 x 4.6 mm; 
(b) detection: 260 nm; (c) flow rate: 1.0 mL min"1; (d) eluents: 
A: 0.1 M aq TEAA (pH 7.0), B: acetonitrile-0.1 M aq TEAA 
(pH 7.0) 8 : 2 (v/v); A: 0.1% aq TFA (pH 2.0), B: 0.1% in 
TFA acetonitrile-water 8 : 2 (v/v); (e) gradient: 5-35% (v/v) 
B in A during 30 min or 5-22.5% (v/v) B in A during 40 min 
(in case of compounds 9-11). UV: PE Lambda 10 instru-
ment. Mass spectrometry: Finnigan MAT TSQ 7000, 
electrospray (ESI) or nanoelectrospray28 or Bruker Reflex III 
MALDI [(in case of compounds 9, 10 and 11) reflectron 
positive mode in 2-3 kDa window using sinapic or 2,5-
dihydroxybenzoic acid matrices (the latter is better than sinapic 
acid in the 1-2 kDa region)]. Calculated molecular weights for 
peptide nucleic acids are given for the most intensive mono-
isotopic peaks. 
HPLC peaks were identified by MS analysis of the fractions 
obtained after purification of the product. 
Solution phase coupling studies 
Reagents used in all coupling experiments have been utilized as 
stock solutions in anhydrous DMF if not stated otherwise. 
To a 0.196 M solution of t monomer in D M F (10.2 pL, 
2.0 pmol) one of the following solutions was added: 
1. 0.77 M solution of HATU (2.6 pL, 2.0 pmol), 0.6 M 
solution of lutidine (3.7 pL, 2.2 pmol) and 0.4 M solution of 
DIPEA (5.0 pL, 2.0 pmol). 
2. 0.78 M solution of BET (2.8 pL, 2.2 pmol), 0.4 M solution 
of DIPEA (11.0 pL, 4.4 pmol). 
3. 0.51 M solution of CMP (4.3 pL, 2.2 pmol) and 0.4 M 
solution of DIPEA (11.0 pL, 4.4 pmol). 
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After 2 min preactivation, to each of the above solutions tert-
butyl phenylalaninate (3.0 pmol) in D M F (6.0 pL) was added 
and the reaction mixture was made up to a total volume of 27.5 
pL with DMF. After S min, S pL samples of the reaction solu-
tion were analyzed by HPLC (Rutin column, 1-80% (v/v) eluent 
B in A during 47 min) at 220 nm. Yields were determined by a 
calibration curve (peak area (S p L solution, 220 nm) = ^concen-
tration of t monomer)]. 
Solid phase synthesis (Tables 2 and 4) 
Fmoc deprotection was performed with 20% (v/v) piperidine-
D M F (1.5 mL) for 5 min, followed by washing with D M F (2 x 
1 mL). 100 pL of this solution was added to EtOH (2 mL) and 
its absorbance was measured at 290 nm.33 
The accuracy of the sample collection and absorbance 
determination is ±2.4% based on data from six independent 
measurements. [0.700; 0.717; 0.713; 0.718; 0.681; 0.730, where 
x = 0.7098 and o = 0.0171]. 
Each coupling was followed with capping with a D M F solu-
tion (1.5 mL) containing 5% (v/v) A c 2 0 and 6% (v/v) lutidine 
for 5 min. 
Coupling conditions in initial studies on TentaGel™ 
and Wang resins: monomer (0.1 M so ln ) -HATU-DIPEA-
lutidine = 4 : 3.6 :4.4 :4.4 equiv. in D M F for 20 min after 2 min 
preactivation. Optimal coupling conditions: monomer -
HATU-DIPEA-lut id ine = 3 : 2.7 : 3.3 : 3.3 equiv. in D M F for 
20 min after 2 min preactivation applied on Wang and CPG 
supports. PNA oligomers were synthesized manually using a 
home-built shaker in 3 m L Whatman syringes equipped with 
a 1 pm P T F E filter (catalogue no. 6984-0310 ) on 25-50 mg of 
resin on which the first unit was Gly (TG-OH, 0.25 mmol g~' or 
H-B lC-CPG, 40 pmol g" ') or Lys (Wang, 0.5 mmol g"1, syn-
thesis scale: 12.5-25 pmol). Cleavage: 25% aq NH } , 16 h, 50 "C 
(TG-OH and CPG); in the case of Wang resin first a mixture of 
TFA and 1,3-dimethoxybenzene 9 : 1 (v/v) (1 mL) was added 
and it was allowed to react for 3 h. Subsequently, it was treated 
with aq N H 3 in the same way as above. 
Using 3 equiv. monomer excess on Wang resin the following 
coupling yields (%) were achieved: 96 (a + a); 100 (a + c); 100, 
100,96,100 (a + t); 94 ,99 ,95 ,94 (c + a); 100,100,100 (c + g); 
93,100 (g + g); 100,100,96,100 (g + t); 100,94,100,100 (t + 
c); 100 (t + g). During synthesis on TentaGel™ there was no 
problem with the remaining 7 couplings which were not studied 
in detail on TentaGel™ resin: (a + g); (c + t); (g + a); (g + c); 
(t + a); (t + t) couplings, only (c + c) was a bit low (93, 100, 
89%). (a + c), for example, represents coupling of monomer a 
to c that is connected to another monomer or amino acid on the 
support. 
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Recent progress in peptide synthesis resulted in the elaboration of novel coupling agents. One successful approach involves the 
application of thiazolium salts, e.g. 2-bromo-3-ethyl-4-methylthiazolium tetrafluoroborate (BEMT) [1-3]. This compound can be 
prepared from 2-bromo-3-ethyl-4-methylthiazole [1, 2], We have found that a simpler analogue, 2-bromo-3-ethylthiazolium 
tetrafluoroborate (BET), can be prepared in convenient steps from the commercially available 2-aminothiazole using the procedure 
by Dondoni el al. |4] to obtain 2-bromothiazole which, in turn, was readily transformed into the title compound. In our experience 
BET is a highly efficient coupling reagent in the synthesis of peptide nucleic acid (PNA) oligomers in solution phase. 
To a stirred solution of 2-bromothiazole [4] (1.78 mL, 20.0 mmol) in 1,2-dichloroethane (DCE, 20 mL) the solution of 
triethyloxonium tetrafluoroborate (11.4 g, 60.0 mmol) in DCE(60 mL) was added over 45 min. at 80 °C. When the reaction was 
complete (16 h) according to TLC (n-buthanol : acetic acid : water = 4:1:1) the solution was concentrated in vacuo. After the 
residue was precipitated from diethyl ether it was recrystallized from abs. acetonitrile/ethyl acetate to afford white plates. Yield: 
4.48 g (80 %). 
Mp: 137.9-139.2 °C. 
*H NMR (DMSO-d6 , 500 MHz, 5, ppm): 1.47 (t, J= 7.0 Hz, 3H, CH 2 C7/ j ) ; 4.52 (q, J= 7.0 Hz, 2H, C / / 2 CH 3 ) ; 8.35 (d, J = 4.1 
Hz, 1H, aryl); 8.56 (d , , 7=4 .1 Hz, 1H, aryl). 
1 3 C NMR (DMSO-d6 , 125 MHz, 5, ppm): 14.19 (CH 2 CH 3 ) ; 50.61 (CH 2 CH 3 ) ; 127.45 (C-5); 137.73 (C-4); 146.50 (C-2). 
ESI-MS (m/z, %): 191.8 (100, [ C 5 H ? 7 9 B r N S ] + ) ; 193.8 (97, [C 5 H 7 8 1 BrNS] + ) . 
Anal. cald. for C 5 H ? B B r F 4 N S (279.891): C, 21.45; H, 2.52; Br, 28.55; F, 27.15; N, 5.00; S, 11.46; found C, 21.47; H, 2.51; Br, 
28.52; F, 27.20; N, 5.01; S, 11.44. 
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